Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

 
<< vorige    volgende >>
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             2122 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1001 EP-1326: The role of PET CT in the IMRT of cervical cancer: the experience of the Institute of Candiolo Cattari, G.
 2016
 119 S1 p. S621-
1 p.
 artikel
1002 EP-1445: The role of radiotherapy in the conservative treatment in bladder cancer elderly patients Mariaquila Santoro, M.S.
 2016
 119 S1 p. S670-S671
2 p.
 artikel
1003 EP-2019: The safety and efficacy of external beam radiotherapy combined yttrium 90 SIRT Wang, T.H.
 2016
 119 S1 p. S953-S954
2 p.
 artikel
1004 EP-1436: The superior vena cava syndrome (SVCS): role of the radiotherapy Mariaquila Santoro, M.S.
 2016
 119 S1 p. S667-
1 p.
 artikel
1005 EP-1073: The usefulness of 18F-FDG PET and PET-based considerations in locally advanced nasopharyngeal cancer Yoon, H.I.
 2016
 119 S1 p. S516-
1 p.
 artikel
1006 EP-1703: The usefulness of VMAT in patients irradiated to the chest wall after left-sided mastectomy Spalek, M.
 2016
 119 S1 p. S796-
1 p.
 artikel
1007 EP-1302: The utility of Squamous Cell Carcinoma SCCAg as a marker for treatment response or relapse Pietrzak, L.
 2016
 119 S1 p. S611-
1 p.
 artikel
1008 EP-1238: Thoracic re-irradiation following curative intent radiotherapy for non-small cell lung cancer Scobie, S.
 2016
 119 S1 p. S586-S587
2 p.
 artikel
1009 EP-1172: Thyroid tolerance in adjuvant supraclavicular fossa nodal radiotherapy in breast cancer Pettit, L.
 2016
 119 S1 p. S558-
1 p.
 artikel
1010 EP-1751: Time-resolved analysis of Varian RPM-gated exposures on three versions of Truebeam linac King, R.B.
 2016
 119 S1 p. S820-
1 p.
 artikel
1011 EP-1187: T-lysyal based cream (Repalysyal) in the prevention of acute skin toxicity in breast cancer patients Rese, A.
 2016
 119 S1 p. S564-S565
2 p.
 artikel
1012 EP-1440: Tokuhashi Scoring and Karnofsky Scale: correlated with prognosis in spinal cord compression? Esteban, D.
 2016
 119 S1 p. S669-
1 p.
 artikel
1013 EP-1707: Tomotherapy dose painting hypofractionated treatments on GBM based on DW-MRI: a feasibility study Orlandi, M.
 2016
 119 S1 p. S798-
1 p.
 artikel
1014 EP-1299: Tomotherapy for anal cancer: analysis of toxicity and response in a dual institution experience Bonomo, P.
 2016
 119 S1 p. S609-S610
2 p.
 artikel
1015 EP-1514: γTools: a new multipurpose phantom for end-to-end tests in Gamma Knife SRS treatments Calusi, S.
 2016
 119 S1 p. S700-
1 p.
 artikel
1016 EP-1711: To revise helical irradiation of the total skin HITS as completed-HITS in cutaneous lymphoma patient Tien, H.J.
 2016
 119 S1 p. S800-
1 p.
 artikel
1017 EP-1675: Total body irradiation with Tomotherapy Simon, L.
 2016
 119 S1 p. S782-S783
2 p.
 artikel
1018 EP-1294: Total mesorectal excision vs. local excision following preoperative RT for "early" cT3 rectal cancer Shin, Y.
 2016
 119 S1 p. S608-
1 p.
 artikel
1019 EP-1391: Total skin irradiation using helical tomotherapy: a novel experience and report of three cases Okuma, K.
 2016
 119 S1 p. S649-
1 p.
 artikel
1020 EP-1094: Total tumour volume predicts response in head and neck cancer: regression tree analysis and models Dua, B.
 2016
 119 S1 p. S526-S527
2 p.
 artikel
1021 EP-1895: Towards adaptive radiotherapy: a new registration-segmentation framework for focal prostate cancer Feng, Y.
 2016
 119 S1 p. S896-S897
2 p.
 artikel
1022 EP-1815: Towards adaptive Tomotherapy: planning CT to MVCT deformable image registration for dose calculation Branchini, M.
 2016
 119 S1 p. S851-S852
2 p.
 artikel
1023 EP-1834: Towards MRI-only radiotherapy planning: “patch-based method” for generation of brain pseudo-CT Aouadi, S.
 2016
 119 S1 p. S861-
1 p.
 artikel
1024 EP-1053: Toxicity and clinical outcome for patients treated for advanced head and neck cancer with VMAT-SIB Villa, E.
 2016
 119 S1 p. S508-S509
2 p.
 artikel
1025 EP-1481: Toxicity of concomitant application of radiotherapy with „new targeted therapies“ Geier, M.S.
 2016
 119 S1 p. S684-S685
2 p.
 artikel
1026 EP-1369: Toxicity profile with hypofractionated RT for localized prostate cancer: compared 3D-CRT vs VMAT Magli, A.
 2016
 119 S1 p. S639-
1 p.
 artikel
1027 EP-1866: Traceable calibration chain of PET/CT scanners for I-124 Joulaeizadeh, L.
 2016
 119 S1 p. S880-
1 p.
 artikel
1028 EP-1783: Translational and rotational set-up uncertainties in Head and Neck cancer treatments using CBCT Di Biase, M.
 2016
 119 S1 p. S835-S836
2 p.
 artikel
1029 EP-1056: Treatment delays are associated with disease upstaging in oropharyngeal squamous cell carcinoma Baker, S.
 2016
 119 S1 p. S510-
1 p.
 artikel
1030 EP-1634: Treatment of extremity soft tissue sarcoma using protons - robustness of single and matching fields Knäusl, B.
 2016
 119 S1 p. S762-S763
2 p.
 artikel
1031 EP-1759: Treatment of moving targets with active scanning carbon ion beams Fossati, P.
 2016
 119 S1 p. S824-
1 p.
 artikel
1032 EP-1119: Treatment of Subependymal giant cell astrocytoma (SEGA): Is there a place for radiotherapy? Atef Kamel, R.
 2016
 119 S1 p. S537-
1 p.
 artikel
1033 EP-1121: Treatment outcome of adult brain stem Glioma: a single institution experience Chaudry, S.
 2016
 119 S1 p. S538-
1 p.
 artikel
1034 EP-1052: Treatment outcome of induction bio-chemotherapy followed by IMRT in advanced NPC patients Lin, P.J.
 2016
 119 S1 p. S508-
1 p.
 artikel
1035 EP-1680: Treatment planning of stereotactic radiosurgery for single brain metastases: impact of leaf width Lamers-Kuijper, E.
 2016
 119 S1 p. S784-S785
2 p.
 artikel
1036 EP-1668: Treatment planning study of c-IMAT versus s-IMRT in cervical and upper thoracic esophageal carcinoma Zhang, R.
 2016
 119 S1 p. S779-
1 p.
 artikel
1037 EP-1958: Treatment results of Mammosite catheter in combination with whole breastirradiation Gitt, A.
 2016
 119 S1 p. S929-
1 p.
 artikel
1038 EP-2018: Treatment with high dose rate plesiotherapy and custom moulds in skin cancer. Long term results Membrive, I.
 2016
 119 S1 p. S953-
1 p.
 artikel
1039 EP-1136: Treatment with radiosurgery (stereotactic radiotherapy) in single session in brain metastases Vargas Arrabal, P.
 2016
 119 S1 p. S544-
1 p.
 artikel
1040 EP-1859: Tumor control assessment on cervical lymph nodes using texture analysis on CT and T2w-MRI images Scalco, E.
 2016
 119 S1 p. S876-S877
2 p.
 artikel
1041 EP-1956: Twitter as a tool for radiotherapy medical education: The #radonc Journal Club Simcock, R.
 2016
 119 S1 p. S928-
1 p.
 artikel
1042 EP-1937: UK stereotactic ablative radiotherapy trials normal tissue dose constraints tolerance consensus Hanna, G.G.
 2016
 119 S1 p. S919-
1 p.
 artikel
1043 EP-1536: Uncertainties in dose calculations for radiation treatment of breast cancer after mastectomy Chakarova, R.
 2016
 119 S1 p. S711-S712
2 p.
 artikel
1044 EP-1520: Uncertainties in film measurements of dose area product Wright, T.
 2016
 119 S1 p. S704-
1 p.
 artikel
1045 EP-1032: Unilateral neck radiotherapy in HPV-related tonsillar carcinomas Thippu Jayaprakash, K.
 2016
 119 S1 p. S499-S500
2 p.
 artikel
1046 EP-1254: Updated outcomes for patients treated with SABR for lung cancer at the Leeds Cancer Centre Murray, P.
 2016
 119 S1 p. S592-S593
2 p.
 artikel
1047 EP-2004: Urethra dose homogeneity constraints in LDR prostate brachytherapy could diminish urinary morbidity González-Pérez, V.
 2016
 119 S1 p. S947-S948
2 p.
 artikel
1048 EP-1083: Usefulness of PET/CT in definition of treatment volumes of head and neck tumors Luigi Perrone, L.P.
 2016
 119 S1 p. S520-S521
2 p.
 artikel
1049 EP-2098: Use of a bladder minimum contour for prostate treatment planning to increase comfort and efficiency Evans, C.
 2016
 119 S1 p. S987-
1 p.
 artikel
1050 EP-1710: Use of FFF beams for SBRT treatments: impact of the size of the PTV? Vieillevigne, L.
 2016
 119 S1 p. S799-S800
2 p.
 artikel
1051 EP-1414: Using a DVH registry standardizes IMRT-CSI planning and reduces V20 in non-target tissues Létourneau, M.
 2016
 119 S1 p. S658-
1 p.
 artikel
1052 EP-1892: Using deformable image registration to integrate diagnostic MRI into the planning pathway for HNSCC Chuter, R.
 2016
 119 S1 p. S894-S895
2 p.
 artikel
1053 EP-1818: Using ROIs projected on EPID as a predictor of plan deterioration due to anatomical changes Piron, O.
 2016
 119 S1 p. S852-S853
2 p.
 artikel
1054 EP-1219: Utilisation of new functional imaging in NSCLC radiotherapy: Can we use DW-MRI? Al Daly, M.
 2016
 119 S1 p. S577-S578
2 p.
 artikel
1055 EP-2083: Utilising flattening filter free (FFF) beams to reduce treatment delivery times for breast patients Le Mottee, M.
 2016
 119 S1 p. S981-S982
2 p.
 artikel
1056 EP-1329: Vaginal and pelvic recurrences of endometrial carcinoma with BT HDR alone or in combination with EBRT Gribaudo, S.
 2016
 119 S1 p. S622-
1 p.
 artikel
1057 EP-1968: Vaginal mucosal doses in the treatment of cervical cancer using HDR brachytherapy Keough, W.
 2016
 119 S1 p. S932-S933
2 p.
 artikel
1058 EP-1573: Validation of a dedicated Intra-operative radiotherapy TPS: an innovative tool for image-guided IORT Ciccotelli, A.
 2016
 119 S1 p. S729-S730
2 p.
 artikel
1059 EP-1849: Validation of synthetic CTs for MR-only planning of brain cancer Glide-Hurst, C.
 2016
 119 S1 p. S870-
1 p.
 artikel
1060 EP-1523: Validation of the dosimetric algorithm Acuros XB and the impact of its usage in SBRT treatments Younes, T.
 2016
 119 S1 p. S705-
1 p.
 artikel
1061 EP-1880: Validation of the use of digital camera for the prediction of skin toxicity in breast radiotherapy Poli, M.
 2016
 119 S1 p. S888-S889
2 p.
 artikel
1062 EP-1316: Value of imaging modalities in predicting pelvic lymph node metastases for uterine cervical cancer Jung, W.K.
 2016
 119 S1 p. S617-
1 p.
 artikel
1063 EP-1858: Variation of apparent diffusion coefficient in penile bulb after radiotherapy Volonghi, P.
 2016
 119 S1 p. S875-S876
2 p.
 artikel
1064 EP-1590: Verification of small-field VMAT plans using a 2D detector array in a rotational phantom Swinnen, A.
 2016
 119 S1 p. S738-S739
2 p.
 artikel
1065 EP-1427: Vertebral compression fracture of spinal metastasis from colorectal cancer after radiotherapy Lee, J.
 2016
 119 S1 p. S663-S664
2 p.
 artikel
1066 EP-2020: Vertical type surface brachytherapy applicator improvement with a 3d printed dose compensation body Buchauer, K.
 2016
 119 S1 p. S954-
1 p.
 artikel
1067 EP-1029: 20 v. 25-35 fractions in Oropharyngeal Carcinoma chemoIMRT: Could fraction number be de-escalated? Cheng, B.
 2016
 119 S1 p. S498-S499
2 p.
 artikel
1068 EP-1787: View of interest of automatic registration for CBCT localisation of head and neck cancer Draulans, C.
 2016
 119 S1 p. S837-
1 p.
 artikel
1069 EP-1904: Virtual CT for adaptive prostate radiotherapy based on CTCBCT deformable image registration Cassetta Junior, F.R.
 2016
 119 S1 p. S902-S903
2 p.
 artikel
1070 EP-1461: Virtual imaging for patient information on radiotherapy planning and delivery Sulé-Suso, J.
 2016
 119 S1 p. S677-
1 p.
 artikel
1071 EP-1755: Visualization of respiratory and cardiac motion via TomoTherapy exit detector fluence Corradini, N.
 2016
 119 S1 p. S822-S823
2 p.
 artikel
1072 EP-2041: Vitamin D protects HUVEC from RT-induced senescence and apoptosis by modulating MAPK/SirT1 axis Marampon, F.
 2016
 119 S1 p. S963-S964
2 p.
 artikel
1073 EP-1234: VMAT based lung ablative radiotherapy: primary lesions and metastases Farga, D.
 2016
 119 S1 p. S585-
1 p.
 artikel
1074 EP-1655: VMAT FFF irradiation in deep inspiration breath hold Demoucron, J.
 2016
 119 S1 p. S773-
1 p.
 artikel
1075 EP-1678: VMAT in locally advanced lung cancer; does it add benefit? Kamaleldin, M.
 2016
 119 S1 p. S783-S784
2 p.
 artikel
1076 EP-1556: VMAT in nasopharyngeal tumor: clinical implications after a change in the dose calculation algorithm Cilla, S.
 2016
 119 S1 p. S721-S722
2 p.
 artikel
1077 EP-1600: VMAT lung SBRT: 3D evaluation in pretreatment patient QA and in vivo dose verification Villaggi, E.
 2016
 119 S1 p. S744-
1 p.
 artikel
1078 EP-1701: VMAT or IMRT- what is better solution in sparing bone marrow in WPRT of patients after prostatectomy Poncyljusz, M.
 2016
 119 S1 p. S795-
1 p.
 artikel
1079 EP-1660: VMAT planning and delivery for total marrow irradiation Houghton, S.
 2016
 119 S1 p. S775-
1 p.
 artikel
1080 EP-1562: VMAT pre-treatment verification using Octavius 4D system: from simple to more complex plans Aslian, H.
 2016
 119 S1 p. S724-S725
2 p.
 artikel
1081 EP-1050: Volume definition in radiotherapy planning for thyroid cancer: a retrospective observational study Farina, E.
 2016
 119 S1 p. S507-S508
2 p.
 artikel
1082 EP-1047: Volume, FDG-PET and ADC responses could predict a similar prognostic benefit as HPV status Gouw, Z.
 2016
 119 S1 p. S506-
1 p.
 artikel
1083 EP-1635: Volumetric modulated arc therapy optimization including dynamic collimator rotation Fix, M.K.
 2016
 119 S1 p. S763-
1 p.
 artikel
1084 EP-1137: Volumetric Modulated Arc Therapy (VMAT) and simultaneus boost for brain metastases patients Papaleo, A.
 2016
 119 S1 p. S544-
1 p.
 artikel
1085 EP-1884: Voxel based topological PET SUV changes of bone marrow for LACC RT effect on hematological toxicity Gulyban, A.
 2016
 119 S1 p. S890-S891
2 p.
 artikel
1086 EP-2104: Waiting times for IMRT as a Quality Indicator: A study from a Tertiary Hospital in Saudi Arabia Mulla, Z.
 2016
 119 S1 p. S989-S990
2 p.
 artikel
1087 EP-1209: WBRT plus SRT versus WBRT alone or SRT alone for brain metastases from non-small cell lung cancer Suwinski, R.
 2016
 119 S1 p. S573-S574
2 p.
 artikel
1088 EP-2102: “We’re all here for the patient”: exploring the process of interprofessional learning Coleman, K.
 2016
 119 S1 p. S989-
1 p.
 artikel
1089 EP-1160: What drives post-mastectomy radiation therapy receipt in T2N0 patients? Fisher, C.
 2016
 119 S1 p. S553-
1 p.
 artikel
1090 EP-1456: What is the cost of reducing cardiac morbidities when treating breast cancers with radiotherapy? Arunsingh, M.
 2016
 119 S1 p. S675-
1 p.
 artikel
1091 EP-1507: Which detector for small photon field measurements? Casati, M.
 2016
 119 S1 p. S696-S697
2 p.
 artikel
1092 EP-1689: Which technique is dosimetrically superior in the treatment of breastcancer: VMAT or Fixed Field IMRT Murphy, S.
 2016
 119 S1 p. S788-S789
2 p.
 artikel
1093 EP-1451: Workflow Management: Impact on the ergonomics of a Radiotherapy department in a developing country Miriyala, R.
 2016
 119 S1 p. S673-
1 p.
 artikel
1094 EP-2107: Work satisfaction and motivation of radiation therapists. A qualitative study Kup, P.G.
 2016
 119 S1 p. S991-
1 p.
 artikel
1095 EP-1173: 10-years results of accelerated hypofractionated RT for breast cancer Gladilina, I.
 2016
 119 S1 p. S558-S559
2 p.
 artikel
1096 Extreme hypofractionation: indications and results Widmark, A.
 2016
 119 S1 p. S139-
1 p.
 artikel
1097 Fully automated treatment plan generation using ErasmusiCycle - the Rotterdam experience Dirkx, M.L.P.
 2016
 119 S1 p. S145-
1 p.
 artikel
1098 Implementation of new standards in your department: a RTT perspective Baker, A.
 2016
 119 S1 p. S136-S137
2 p.
 artikel
1099 Improvement of delineation quality of organs at risk in head and neck using the consensus guidelines Steenbakkers, R.
 2016
 119 S1 p. S137-S138
2 p.
 artikel
1100 Information for Authors 2016
 119 S1 p. ii-
1 p.
 artikel
1101 Intra-fraction motion characterisation of head-and-neck tumors using cine-MRI Bruijnen, T.
 2016
 119 S1 p. S149-
1 p.
 artikel
1102 OC-0257: A Bayesian network model for acute dysphagia prediction in the clinic for NSCLC patients Jochems, A.T.C.
 2016
 119 S1 p. S118-S119
2 p.
 artikel
1103 OC-0143: A Bayesian randomisation trial of IMRT vs. PSPT for locally advanced non-small cell lung carcinoma Liao, Z.
 2016
 119 S1 p. S65-
1 p.
 artikel
1104 OC-0368: Accurate CBCT based dose calculations Thing, R.S.
 2016
 119 S1 p. S171-S172
2 p.
 artikel
1105 OC-0272: A comparison of CTCAE version 3 and 4 in assessing oral mucositis in oral/oropharyngeal carcinoma Hickman, M.
 2016
 119 S1 p. S127-
1 p.
 artikel
1106 OC-0066: Adaptive cone-beam CT planning improves progression-free survival for I-125 prostate brachytherapy Peters, M.
 2016
 119 S1 p. S29-
1 p.
 artikel
1107 OC-0364: Adaptive radiotherapy for advanced lung cancer ensures target coverage and decreases lung dose Moeller, D.S.
 2016
 119 S1 p. S169-
1 p.
 artikel
1108 OC-0237: Adding Notch inhibition increases efficacy of standard of care treatment in glioblastoma Yahyanejad, S.
 2016
 119 S1 p. S107-S108
2 p.
 artikel
1109 OC-0167: Advanced left-side breast cancer: does VMAT allow doses of organs at risk to be reduced? Yu, P.C.
 2016
 119 S1 p. S78-S79
2 p.
 artikel
1110 OC-0551: Advantage of IMPT over IMRT in treatment of gynaecological cancer with para-aortic nodal involvement Van de Sande, M.
 2016
 119 S1 p. S263-S264
2 p.
 artikel
1111 OC-0253: A high sensitivity plastic scintillation detector for in vivo dosimetry of LDR brachytherapy Therriault-Proulx, F.
 2016
 119 S1 p. S116-
1 p.
 artikel
1112 OC-0238: Akt1 facilitates DNA double-strand breaks repair through a direct physical interaction with DNA-PKcs Toulany, M.
 2016
 119 S1 p. S108-
1 p.
 artikel
1113 OC-0082: alidation of MR based dose calculation of prostate cancer treatments Christiansen, R.L.
 2016
 119 S1 p. S38-S39
2 p.
 artikel
1114 OC-0529: A MR-based IGRT platform using the KPC transgenic mouse model of pancreatic cancer Thompson, J.
 2016
 119 S1 p. S250-
1 p.
 artikel
1115 OC-0341: Anal dose reduction for radiotherapy of prostate cancer does not lead to less rectal incontinence Pos, F.
 2016
 119 S1 p. S157-
1 p.
 artikel
1116 OC-0071: Analysis and reporting patterns of failure in the era of IMRT: head and neck cancer applications Mohamed, A.S.R.
 2016
 119 S1 p. S32-S33
2 p.
 artikel
1117 OC-0274: Analysis of set-up errors in head and neck cancer treated with IMRT technique assessed by CBCT Delishaj, D.
 2016
 119 S1 p. S127-
1 p.
 artikel
1118 OC-0067: An automated patient-specific and quantitative approachfor deformable image registration evaluation Kierkels, R.G.
 2016
 119 S1 p. S29-S30
2 p.
 artikel
1119 OC-0367: A Neural Network analysis to support Adaptive RT strategies: a multicenter retrospective study Guidi, G.
 2016
 119 S1 p. S170-S171
2 p.
 artikel
1120 OC-0382: A novel concept to tumour targeting: inverse dose-painting or targeting the "Low uptake drug volume" Yaromina, A.
 2016
 119 S1 p. S179-
1 p.
 artikel
1121 OC-0138: Apnea-like suppression of respiratory motion: first clinical evaluation Peguret, N.
 2016
 119 S1 p. S62-S63
2 p.
 artikel
1122 OC-0621: A population based library of plans for rectal cancer: design and prospects for margin reduction Hartgring, L.
 2016
 119 S1 p. S295-S296
2 p.
 artikel
1123 OC-0064: A prediction model for biochemical failure after salvage Iodine-125 prostate brachytherapy Peters, M.
 2016
 119 S1 p. S28-S29
2 p.
 artikel
1124 OC-0059: A radiation dose-response relationship for risk of heart failure in survivors of Hodgkin lymphoma Aleman, B.M.P.
 2016
 119 S1 p. S25-S26
2 p.
 artikel
1125 OC-0074: A real time in vivo dosimeter integrated in the radiation protection disc for IORT breast treatment Iori, M.
 2016
 119 S1 p. S34-
1 p.
 artikel
1126 OC-0354: Artificial neural network for bladder dose interfractional variation prediction in GYN brachytherapy Siavashpour, Z.
 2016
 119 S1 p. S163-
1 p.
 artikel
1127 OC-0168: A simple visual test is adequate for testing vmDIBH reproducibility in locoregional breast cancer Den Otter, L.A.
 2016
 119 S1 p. S79-S80
2 p.
 artikel
1128 OC-0414: Assessing 4DCT-ventilation as a functional imaging modality for thoracic radiation therapy Vinogradskiy, Y.
 2016
 119 S1 p. S192-S193
2 p.
 artikel
1129 OC-0419: Association between pathology and texture features of multi parametric MRI of the prostate Kuess, P.
 2016
 119 S1 p. S195-S196
2 p.
 artikel
1130 OC-0079: Automated instead of manual planning for lung SBRT? Aplan comparison based on dose-volume statistics Vanderstraeten, B.
 2016
 119 S1 p. S37-
1 p.
 artikel
1131 OC-0266: Automated treatment plan generation for advanced stage NSCLC patients Della Gala, G.
 2016
 119 S1 p. S124-
1 p.
 artikel
1132 OC-0558: Automated VMAT planning in prostate cancer patients using a Single Arc SIB Technique Simpson, N.
 2016
 119 S1 p. S268-
1 p.
 artikel
1133 OC-0542: Benign tumours among long-term childhood cancer survivors: a DCOG LATER record linkage study Kok, J.
 2016
 119 S1 p. S257-S258
2 p.
 artikel
1134 OC-0130: Biomarker-based hypoxia-adapted radiochemotherapy: preclinical study in HPV+/- H&N cancer xenografts Koi, L.
 2016
 119 S1 p. S59-
1 p.
 artikel
1135 OC-0252: BrachyView: A novel technique for seed localisation and real-time quality assurance Alnaghy, S.
 2016
 119 S1 p. S115-S116
2 p.
 artikel
1136 OC-0068: Can atlas-based auto-contouring ever be perfect? Schipaanboord, B.W.K.
 2016
 119 S1 p. S30-S31
2 p.
 artikel
1137 OC-0467: Can a VMAT radiotherapy planning solution match brachytherapy in cervical cancers? Buck, E.
 2016
 119 S1 p. S221-
1 p.
 artikel
1138 OC-0135: Can we select stage I NSCLC patients at high risk for early death prior to SBRT treatment? Klement, R.
 2016
 119 S1 p. S61-
1 p.
 artikel
1139 OC-0247: Carbon ion radiotherapy for adenoid cystic carcinomas invading the skull base Hasegawa, A.
 2016
 119 S1 p. S113-
1 p.
 artikel
1140 OC-0060: Cardiac risk prediction: Moving beyond a mean heart dose model? Maraldo, M.
 2016
 119 S1 p. S26-
1 p.
 artikel
1141 OC-0057: Cardiotoxicity and cardiac substructure dosimetry in doseescalated lung radiotherapy Vivekanandan, S.
 2016
 119 S1 p. S24-S25
2 p.
 artikel
1142 OC-0372: Changes in student attitudes following a pre-registration interprofessional learning experience Coleman, K.
 2016
 119 S1 p. S173-S174
2 p.
 artikel
1143 OC-0342: Chemoradiotherapy in high-risk prostate cancer (QRT SOGUG trial): Preliminary report Foro Arnalot, P.
 2016
 119 S1 p. S157-
1 p.
 artikel
1144 OC-0454: Clinical outcome in nasopharyngeal carcinoma patients with post-radiation detectable plasma EBV DNA Lin, J.C.
 2016
 119 S1 p. S213-
1 p.
 artikel
1145 OC-0154: Clinical use of dual-energy CT for proton treatment planning to reduce CT-based range uncertainties Wohlfahrt, P.
 2016
 119 S1 p. S70-S71
2 p.
 artikel
1146 OC-0418: Cluster analysis of DCE MRI reveals tumor subregions related to relapse of cervical cancers Torheim, T.
 2016
 119 S1 p. S195-
1 p.
 artikel
1147 OC-0256: Column generation-based Monte Carlo treatment planning for rotating shield brachytherapy Renaud, M.A.
 2016
 119 S1 p. S118-
1 p.
 artikel
1148 OC-0460: Common errors in basic radiation dosimetry and radiotherapy practice Kry, S.
 2016
 119 S1 p. S216-S217
2 p.
 artikel
1149 OC-0269: Comparison of dosimetric parameters of two techniques with VMAT for head and neck cancers Miyazaki, M.
 2016
 119 S1 p. S125-S126
2 p.
 artikel
1150 OC-0262: Comparison of machine-learning methods for predictive radiomic models in locally advanced HNSCC Leger, S.
 2016
 119 S1 p. S121-S122
2 p.
 artikel
1151 OC-0058: Coronary calcifications in breast cancer patients and association with cardiovascular risk factors Gernaat, S.A.M.
 2016
 119 S1 p. S24-S25
2 p.
 artikel
1152 OC-0255: Correction function for MOSkin readings in realtime in vivo dosimetry in HDR prostate brachytherapy Rossi, G.
 2016
 119 S1 p. S117-S118
2 p.
 artikel
1153 OC-0536: Course of quality of life after radiotherapy for painful bone metastases Westhoff, P.
 2016
 119 S1 p. S254-S255
2 p.
 artikel
1154 OC-0261: CT Image biomarkers improve the prediction of xerostomia and sticky saliva Sijtsema, N.M.
 2016
 119 S1 p. S121-
1 p.
 artikel
1155 OC-0165: Deep inspiration breath hold – can it be detrimental to the heart? Done, B.
 2016
 119 S1 p. S77-S78
2 p.
 artikel
1156 OC-0458: Delivery errors detectability with IQM, a system for real-time monitoring of radiotherapy treatments Marrazzo, L.
 2016
 119 S1 p. S215-S216
2 p.
 artikel
1157 OC-0170: Detection of setup errors with body surface laser scanning system for whole breast irradiation Jiang, P.
 2016
 119 S1 p. S80-S81
2 p.
 artikel
1158 OC-0455: Development of activity pencil beam algorithm using nuclear reaction for innovative proton therapy Nishio-Miyatake, A.
 2016
 119 S1 p. S213-S214
2 p.
 artikel
1159 OC-0270: Development of a model to produce reference parotid dose from anatomical parameters in IMRT of NPC Leung, W.S.
 2016
 119 S1 p. S126-
1 p.
 artikel
1160 OC-0073: Difference in using the TRS-398 code of practice and TG-51 dosimetry protocol for FFF beams Lye, J.
 2016
 119 S1 p. S33-S34
2 p.
 artikel
1161 OC-0141: Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? Paelinck, L.
 2016
 119 S1 p. S64-
1 p.
 artikel
1162 OC-0442: Does miR-210 predict benefit from hypoxia modification in BCON randomised bladder cancer patients? West, C.
 2016
 119 S1 p. S206-
1 p.
 artikel
1163 OC-0461: Does the dosimetric advantage of prone setup persist in small-margin IMRT for gynecological cancer? Heijkoop, S.T.
 2016
 119 S1 p. S217-S218
2 p.
 artikel
1164 OC-0070: Do radiomics features excel human eye in identifying an irradiated tumor? Rat tumor to patient HNSCC Panth, K.
 2016
 119 S1 p. S31-S32
2 p.
 artikel
1165 OC-0363: Dose escalation in lung cancer patients, the dosimetric implications of inter-fractional change Hoffmann, L.
 2016
 119 S1 p. S168-S169
2 p.
 artikel
1166 OC-0283: Dose escalation with contact x-ray brachytherapy to improve organ preservation in rectal cancer Sun Myint, A.
 2016
 119 S1 p. S132-S133
2 p.
 artikel
1167 OC-0399: Dose to heart substructures is associated with non-cancer death after SBRT in stage I NSCLC patients Stam, B.
 2016
 119 S1 p. S187-
1 p.
 artikel
1168 OC-0366: Dosimetric benefit of adaptive proton therapy compared to adaptive photon therapy in cervical cancer Van de Schoot, A.J.A.J.
 2016
 119 S1 p. S170-
1 p.
 artikel
1169 OC-0236: DTP-006: a novel, orally bioavailable hypoxia-activated prodrug Niemans, R.
 2016
 119 S1 p. S107-
1 p.
 artikel
1170 OC-0153: Dual energy CT and iterative metal artefact reduction for accurate tumour delineation Kovacs, D.
 2016
 119 S1 p. S70-
1 p.
 artikel
1171 OC-0077: Dual energy CT proton stopping power ratio calibration:Validation with animal tissues Xie, Y.
 2016
 119 S1 p. S35-S36
2 p.
 artikel
1172 OC-0045: Dual pathway inhibition attenuates radiation-induced pulmonary inflammation and fibrosis Nicolay, N.H.
 2016
 119 S1 p. S18-S19
2 p.
 artikel
1173 OC-0466: Dynamic Wave Arc: initial characterisation, dosimetric benchmark and performance validation Burghelea, M.
 2016
 119 S1 p. S220-S221
2 p.
 artikel
1174 OC-0556: Early clinical outcomes of prostate SABR treated with VMAT-FFF Duffton, A.
 2016
 119 S1 p. S267-
1 p.
 artikel
1175 OC-0353: EBRT and interstitial brachytherapy for recurrent vault carcinomas: Factors influencing the outcomes Engineer, R.
 2016
 119 S1 p. S162-S163
2 p.
 artikel
1176 OC-0340: Effect of dose and image guided radiotherapy (IGRT) on erectile potency (EP) in prostate radiotherapy Murray, J.
 2016
 119 S1 p. S156-S157
2 p.
 artikel
1177 OC-0265: Efficient implementation of random errors in robust optimization for proton therapy with Monte Carlo Barragán Montero, A.M.
 2016
 119 S1 p. S123-S124
2 p.
 artikel
1178 OC-0251: Electromagnetic tracking for error detection in interstitial brachytherapy Kellermeier, M.
 2016
 119 S1 p. S115-
1 p.
 artikel
1179 OC-0235: Enhancing stereotactic radiation schedules using the vascular disrupting agent OXi4503 Horsman, M.R.
 2016
 119 S1 p. S107-
1 p.
 artikel
1180 OC-0362: EPID-based in-vivo dosimetry results: a national statistic Piermattei, A.
 2016
 119 S1 p. S167-S168
2 p.
 artikel
1181 OC-0148: Evaluation of EBRT and HDRBT for inoperable rectal cancer patients: an update of the HERBERT study Rijkmans, E.C.
 2016
 119 S1 p. S67-S68
2 p.
 artikel
1182 OC-0193: Evaluation of models for plan QA using fully automated Pareto-optimal plans for prostate patients Wang, Y.
 2016
 119 S1 p. S89-
1 p.
 artikel
1183 OC-0285: Experimental benchmarking of a probe-format calorimeter for use as an absolute clinical dosimeter Renaud, J.
 2016
 119 S1 p. S133-S134
2 p.
 artikel
1184 OC-0139: Expert knowledge vs. data-driven algorithms: Bayesian prediction models for post-radiotherapy dyspnea Deist, T.M.
 2016
 119 S1 p. S62-S63
2 p.
 artikel
1185 OC-0446: Extra-cranial SBRT in patients with oligometastatic disease: a dose-escalation study Deodato, F.
 2016
 119 S1 p. S208-S209
2 p.
 artikel
1186 OC-0450: Failure pattern and salvage treatment after radical treatment of head and neck cancer Pagh, A.
 2016
 119 S1 p. S210-
1 p.
 artikel
1187 OC-0264: Fast biological RBE modeling for carbon ion therapy using the repair-misrepair-fixation (RMF) model Kamp, F.
 2016
 119 S1 p. S122-S123
2 p.
 artikel
1188 OC-0416: FDG-PET can objectively quantify esophageal doseresponse and toxicity during radiation therapy Niedzielski, J.
 2016
 119 S1 p. S193-S194
2 p.
 artikel
1189 OC-0557: Feasibility of single fraction HDR brachytherapy in patients with prostate cancer: a planning study Roos, M.
 2016
 119 S1 p. S267-S268
2 p.
 artikel
1190 OC-0044: Fingolimod mitigates radiation-induced cognitive deficits by restoring dentate gyrus neurogenesis Stessin, A.
 2016
 119 S1 p. S18-
1 p.
 artikel
1191 OC-0480: Five-year clinical outcome of the Phase III ACCORD 12 neoadjuvant trial in rectal cancer Doyen, J.
 2016
 119 S1 p. S230-
1 p.
 artikel
1192 OC-0249: Five-year clinical outcomes after dose-escalated image-guided proton therapy for prostate cancer Bryant, C.
 2016
 119 S1 p. S114-
1 p.
 artikel
1193 OC-0056: FLAME: Influence of dose escalation to 95Gy for prostate cancer on urethra-related toxicity and QOL Van Loon, J.
 2016
 119 S1 p. S24-
1 p.
 artikel
1194 OC-0282: FLAME randomised trial: 95Gy MRI-boost vs 77Gy prostate radiotherapy: toxicity and quality of life Van Vulpen, M.
 2016
 119 S1 p. S132-
1 p.
 artikel
1195 OC-0061: Focal brachytherapy: what dose to what volume? Haworth, A.
 2016
 119 S1 p. S26-S27
2 p.
 artikel
1196 OC-0242: Follow-up time and prediction model performance in a pooled dataset of rectal cancer trials Van Soest, J.
 2016
 119 S1 p. S110-S111
2 p.
 artikel
1197 OC-0132: FoxO proteins and non-functional p53 determine stemness and radiosensitivity of GBM-stem cells Firat, E.
 2016
 119 S1 p. S59-S60
2 p.
 artikel
1198 OC-0286: From pixel to print: clinical implementation of 3D-printing in electron beam therapy for skin cancer Canters, R.
 2016
 119 S1 p. S134-
1 p.
 artikel
1199 OC-0267: Fully automated planning for non-coplanar CyberKnife prostate SBRT - comparison with automatic VMAT Rossi, L.
 2016
 119 S1 p. S124-S125
2 p.
 artikel
1200 OC-0268: Fully automated VMAT plan generation – an international multi-institutional validation study Heijmen, B.
 2016
 119 S1 p. S125-
1 p.
 artikel
1201 OC-0417: Functional imaging using dual energy Computed Tomography and its application in radiation oncology Lapointe, A.
 2016
 119 S1 p. S194-S195
2 p.
 artikel
1202 OC-0582: Gene signatures predict loco-regional control after postoperative radiochemotherapy in HNSCC Schmidt, S.
 2016
 119 S1 p. S278-S280
3 p.
 artikel
1203 OC-0469: Genitalia contouring in anal cancer IMRT; comparisons of volumes with and without a genitalia atlas Brooks, C.
 2016
 119 S1 p. S222-S223
2 p.
 artikel
1204 OC-0441: Genomic amplification of FancA in HNSCC: mechanisms of radioresistance and clinical relevance Hess, J.
 2016
 119 S1 p. S205-S206
2 p.
 artikel
1205 OC-0448: Give me five: extreme hypofractionated IG-IMRT for organ confined prostate cancer Jereczek-Fossa, B.A.
 2016
 119 S1 p. S209-S210
2 p.
 artikel
1206 OC-0160: Growth and oedema related shifts of brain metastasis treated with stereotactic radiosurgery De Vries, K.
 2016
 119 S1 p. S74-S75
2 p.
 artikel
1207 OC-0250: Hadrontherapy as re-irradiation using active beam delivery at CNAO Ciurlia, E.
 2016
 119 S1 p. S114-
1 p.
 artikel
1208 OC-0544: Heterogeneous FDG-guided dose escalation of locally advanced NSCLC, the NARLAL2 phase III trial Moeller, D.S.
 2016
 119 S1 p. S259-
1 p.
 artikel
1209 OC-0062: High-dose-rate HDR boost for localized prostate cancer decreases long term rectum toxicity Aluwini, S.
 2016
 119 S1 p. S27-
1 p.
 artikel
1210 OC-0349: Hippocampal dosimetry predicts the change in neurocognitive functions after whole brain radiotherapy Lin, S.Y.
 2016
 119 S1 p. S161-
1 p.
 artikel
1211 OC-0331: How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis Borras, J.M.
 2016
 119 S1 p. S153-
1 p.
 artikel
1212 OC-0535: How patient-reported urinary symptoms predict impairment of urinary QoL from RT for prostate cancer Cozzarini, C.
 2016
 119 S1 p. S253-S254
2 p.
 artikel
1213 OC-0214: Hybrid MLC and couch tracking Toftegaard, J.
 2016
 119 S1 p. S98-
1 p.
 artikel
1214 OC-0084: Hybrid RapidArc for breast with locoregional lymph node irradiation spares more normal tissue Bucko, E.
 2016
 119 S1 p. S40-
1 p.
 artikel
1215 OC-0548: Hyperthermia treatment planning in the pelvis using thermophysical fluid modelling of the bladder Schooneveldt, G.
 2016
 119 S1 p. S261-S262
2 p.
 artikel
1216 OC-0142: Hypo- vs normofractionated radiation of early breast cancer in the randomised DBCG HYPO trial Offersen, B.V.
 2016
 119 S1 p. S64-S65
2 p.
 artikel
1217 OC-0373: IGRTonline: development and evaluation of a free online course on Image Guided Radiation Therapy Mallick, I.
 2016
 119 S1 p. S174-
1 p.
 artikel
1218 OC-0075: Impact of air around an ion chamber: solid water phantoms not suitable for dosimetry on an MR-linac Hackett, S.
 2016
 119 S1 p. S34-S35
2 p.
 artikel
1219 OC-0158: Impact of breathing guidance and prospective gating on 4DCT image quality: a digital phantom study Pollock, S.
 2016
 119 S1 p. S73-
1 p.
 artikel
1220 OC-0440: Impact of chemokine receptor CXCR4 and its ligand SDF1 expression on loco-regional control in HNSCC Menegakis, A.
 2016
 119 S1 p. S205-
1 p.
 artikel
1221 OC-0532: Improved cost-effectiveness of short-course radiotherapy in elderly or frail glioblastoma patients Baker, S.
 2016
 119 S1 p. S252-
1 p.
 artikel
1222 OC-0463: Improving treatment plan quality of SBRT lung tumors using a new gradient index Van der Bijl, E.
 2016
 119 S1 p. S218-S219
2 p.
 artikel
1223 OC-0273: Including specific symptoms in clinical scoring: predictive modelling and nursing of swallowing pain Nyeng Christiansen, D.
 2016
 119 S1 p. S127-
1 p.
 artikel
1224 OC-0471: Influence of rectum volume on fine-tuning of image registration in bladder adaptive radiotherapy Sier-Wismeijer, L.S.
 2016
 119 S1 p. S223-S224
2 p.
 artikel
1225 OC-0080: In-silico implementation of MRI-60Co based RT: adosimetrical comparison with rectal cancer (SIMBAD) Placidi, E.
 2016
 119 S1 p. S37-S38
2 p.
 artikel
1226 OC-0164: Integrate range shifting in immobilisation for proton therapy: 3D printed materials characterisation Michiels, S.
 2016
 119 S1 p. S77-
1 p.
 artikel
1227 OC-0464: Integration of fMRI and MEG functional maps into a Cyberknife planning system:a feasibility study De Martin, E.
 2016
 119 S1 p. S219-
1 p.
 artikel
1228 OC-0150: Intraluminal brachytherapy in unresectable biliary carcinoma with malignant biliary obstruction Rastogi, N.
 2016
 119 S1 p. S68-S69
2 p.
 artikel
1229 OC-0371: Introduction of a consultant radiographer to stereotactic radiotherapy service Tsang, Y.
 2016
 119 S1 p. S173-
1 p.
 artikel
1230 OC-0550: Investigation of magnetic field effects for the treatment planning of lung cancer Schrenk, O.
 2016
 119 S1 p. S263-
1 p.
 artikel
1231 OC-0540: IOERT after gross total resection combined with EBRT in extremity sarcoma: a pooled analysis Roeder, F.
 2016
 119 S1 p. S256-
1 p.
 artikel
1232 OC-0134: Irradiation-induced plasticity of the cancer stem cell population in prostate cancer Peitzsch, C.
 2016
 119 S1 p. S60-S61
2 p.
 artikel
1233 OC-0481: Late toxicity and cosmesis after APBI with brachytherapy vs WBI: 5-year results of a phase III trial Polgár, C.
 2016
 119 S1 p. S230-S231
2 p.
 artikel
1234 OC-0470: Library of plans in radiotherapy of rectal cancer: feasible and inter-observer consistent? Van Beek, S.
 2016
 119 S1 p. S223-
1 p.
 artikel
1235 OC-0258: Linear-quadratic modeling of acute rectum toxicity in a prostate hypo-fractionation trial Witte, M.
 2016
 119 S1 p. S119-
1 p.
 artikel
1236 OC-0162: Liquid fiducial markers' performance in non small cell lung cancer during radiotherapy Scherman Rydhög, J.
 2016
 119 S1 p. S75-S76
2 p.
 artikel
1237 OC-0212: Liver motion tracking using optical flow cine-MRI registration Seregni, M.
 2016
 119 S1 p. S96-S97
2 p.
 artikel
1238 OC-0260: Local dose predictors of acute urinary toxicity after RT for prostate cancer Improta, I.
 2016
 119 S1 p. S120-S121
2 p.
 artikel
1239 OC-0439: Localization of p16 expression is an important factor to determine radiotherapy response in HNSCC Dok, R.
 2016
 119 S1 p. S204-S205
2 p.
 artikel
1240 OC-0052: Long-term age dependent failure pattern after BCT vs. mastectomy in low-risk breast cancer patients Laurberg, T.
 2016
 119 S1 p. S22-
1 p.
 artikel
1241 OC-0355: Long term analysis of electron vs. HDR boost in breast conservation – an Indian experience Saha, S.
 2016
 119 S1 p. S164-S165
2 p.
 artikel
1242 OC-0541: Long-term results of the AIEOP MH-89 protocol for pediatric Hodgkin lymphoma Robazza, M.
 2016
 119 S1 p. S256-S257
2 p.
 artikel
1243 OC-0356: Long terms results of permanent breast seed implants (PBSI) as partial breast irradiation Pignol, J.P.
 2016
 119 S1 p. S164-
1 p.
 artikel
1244 OC-0240: Lumbarsacral bone marrow modeling of acute hematological toxicity in chemoradiation for anal cancer Franco, P.
 2016
 119 S1 p. S109-S110
2 p.
 artikel
1245 OC-0140: Management of patients with extensive-stage small-cell lung cancer: A European survey of practice Haslett, K.
 2016
 119 S1 p. S63-S64
2 p.
 artikel
1246 OC-0215: Mapping of breathing and cardiac induced motion of lymph node targets in lung cancer patients Schmidt, M.L.
 2016
 119 S1 p. S98-S99
2 p.
 artikel
1247 OC-0144: Maximum response and PCI are important prognostic factors in LD SCLC patients staged with cMRI Eze, C.
 2016
 119 S1 p. S65-S66
2 p.
 artikel
1248 OC-0131: miR-875-5p enhances radiation response of prostate cancer cells via EGFR suppression El Bezawy, R.
 2016
 119 S1 p. S59-
1 p.
 artikel
1249 OC-0332: Modelled effects of hypofractionation on radiotherapy demand in England Mee, T.
 2016
 119 S1 p. S153-S154
2 p.
 artikel
1250 OC-0528: Modelling tissue radiosensitivity and PET hypoxia image contrast in acute and chronic hypoxia Warren, D.R.
 2016
 119 S1 p. S249-S250
2 p.
 artikel
1251 OC-0527: Monitoring mitochondrial complex-I using novel PET probe allows early detection of radiosensitivity Murayama, C.
 2016
 119 S1 p. S249-
1 p.
 artikel
1252 OC-0078: Monte Carlo calculated beam quality correction factors for proton beams Gomà, C.
 2016
 119 S1 p. S36-S37
2 p.
 artikel
1253 OC-0339: More acute proctitis symptoms with hypofractionation (3.4 Gy) than 2 Gy fractions Heemsbergen, W.
 2016
 119 S1 p. S155-S156
2 p.
 artikel
1254 OC-0462: Motion induced interplay effects for hypo-fractionated FFF VMAT treatment of liver tumours Edvardsson, A.
 2016
 119 S1 p. S218-
1 p.
 artikel
1255 OC-0210: Motion management for partial arc VMAT treatments using intra-fractional 2D/3D registration Furtado, H.
 2016
 119 S1 p. S95-S96
2 p.
 artikel
1256 OC-0380: Moving away from binary definition of PTVs: a novel probabilistic approach to PTV definition Tsang, H.
 2016
 119 S1 p. S178-
1 p.
 artikel
1257 OC-0254: MR compatibility of fiber optic sensing for real-time needle tracking Borot de Battisti, M.
 2016
 119 S1 p. S116-S117
2 p.
 artikel
1258 OC-0155: MR-guided multi-atlas based synthetic CT for MR-only radiotherapy of head and neck cancer patients Farjam, R.
 2016
 119 S1 p. S71-S72
2 p.
 artikel
1259 OC-0351: MRI-guided brachytherapy in cervical cancer: high doses to small bowel don't predict late morbidity Petit, C.
 2016
 119 S1 p. S161-S162
2 p.
 artikel
1260 OC-0156: MRI only prostate radiotherapy using synthetic CT images Persson, E.
 2016
 119 S1 p. S72-
1 p.
 artikel
1261 OC-0241: MR radiomics predicting complete response in radiochemotherapy (RTCT) of rectal cancer (LARC) Dinapoli, N.
 2016
 119 S1 p. S110-
1 p.
 artikel
1262 OC-0530: Nanoparticle-enhanced MRI-guided radiation therapy Detappe, A.
 2016
 119 S1 p. S250-S251
2 p.
 artikel
1263 OC-0479: Neoadjuvant chemoradiation for fixed cT3 or cT4 rectal cancer: results of a phase III study Bujko, K.
 2016
 119 S1 p. S229-S230
2 p.
 artikel
1264 OC-0129: Nitroglycerin decreases the hypoxic fraction of non-small cell lung cancer lesions Reymen, B.
 2016
 119 S1 p. S58-S59
2 p.
 artikel
1265 OC-0534: No decline in patient reported outcomes following radiotherapy for breast cancer patients ≥ 60 years Charaghvandi, K.R.
 2016
 119 S1 p. S253-
1 p.
 artikel
1266 OC-0526: Noninvasive imaging of the PD-1/PD-L1 checkpoint in naïve mice and after combined radioimmunotherapy Hettich, M.
 2016
 119 S1 p. S249-
1 p.
 artikel
1267 OC-0152: Novel software modules for treatment planning of 106Ru eye plaque brachytherapy Heilemann, G.
 2016
 119 S1 p. S69-S70
2 p.
 artikel
1268 OC-0555: Organ at risk dose parameters increased by daily anatomic changes in prostate cancer SBRT Faasse-de Hoog, M.
 2016
 119 S1 p. S266-S267
2 p.
 artikel
1269 OC-0147: Organ preservation in T2 T3 NX M0 rectal. French results using the new Papillon 50TM machine Gérard, J.P.
 2016
 119 S1 p. S67-
1 p.
 artikel
1270 OC-0347: Outcome and prognosticators in adult patients with medulloblastoma: a Rare Cancer Network study Atalar, B.
 2016
 119 S1 p. S159-S160
2 p.
 artikel
1271 OC-0537: p16 and high risk-HPV in node positive cutaneous squamous cell carcinoma of the head and neck McDowell, L.
 2016
 119 S1 p. S255-
1 p.
 artikel
1272 OC-0169: Patient information through group sessions to improve knowledge regarding breast cancer radiotherapy Tinggaard Axelsen, M.T.A.
 2016
 119 S1 p. S79-S80
2 p.
 artikel
1273 OC-0472: Patient preference-driven plan optimisation for shared decision making in anal cancer radiotherapy Rønde, H.S.
 2016
 119 S1 p. S224-S225
2 p.
 artikel
1274 OC-0395: Patient selection in head and neck adaptive radiotherapy Brouwer, C.
 2016
 119 S1 p. S185-
1 p.
 artikel
1275 OC-0449: Pattern of failure and disease control in patients treated for glottic cancer in Denmark 1971-2011 Lyhne, N.
 2016
 119 S1 p. S210-
1 p.
 artikel
1276 OC-0343: Pattern of intraprostatic recurrence on multiparametric MRI after radiotherapy for prostate cancer Ariyaratne, H.
 2016
 119 S1 p. S158-
1 p.
 artikel
1277 OC-0445: Patterns of care and outcome analysis of SBRT for liver metastases - a DEGRO database initiative Andratschke, N.
 2016
 119 S1 p. S208-
1 p.
 artikel
1278 OC-0345: Patterns of failure after radiotherapy in pediatric ependymoma: correlation with dose parameters Tensaouti, F.
 2016
 119 S1 p. S158-S159
2 p.
 artikel
1279 OC-0149: Patterns of relapse in rectal cancer patients following preoperative high dose rate brachytherapy Vuong, T.
 2016
 119 S1 p. S68-
1 p.
 artikel
1280 OC-0284: PD-L1 inhibition improves response of pancreatic cancer to radiotherapy Azad, A.
 2016
 119 S1 p. S133-
1 p.
 artikel
1281 OC-0047: PD-L1/PD-L2 gene expression differs in tumor vs. lung tissue in non-small cell lung cancer patients Reynders, K.
 2016
 119 S1 p. S19-S20
2 p.
 artikel
1282 OC-0346: Pediatric diffuse intrinsic pontine glioma re-irradiation: better survival and better time Gandola, L.
 2016
 119 S1 p. S159-
1 p.
 artikel
1283 OC-0381: Perfusion SPECT can quantify radiation-induced changes in the lung after IMRT for NSCLC Farr, K.
 2016
 119 S1 p. S178-S179
2 p.
 artikel
1284 OC-0453: Phase II trial of de-intensified chemoradiotherapy for HPV-associated oropharyngeal cancer Chera, B.
 2016
 119 S1 p. S212-S213
2 p.
 artikel
1285 OC-0357: Pilot study of a remote end-to-end dosimetry audit for IMRT and VMAT treatments Wesolowska, P.
 2016
 119 S1 p. S164-S165
2 p.
 artikel
1286 OC-0560: Plan of the day approach in post prostatectomy radiation therapy Lac, C.
 2016
 119 S1 p. S269-
1 p.
 artikel
1287 OC-0271: Positional accuracy valuation of a three dimensional printed device for head and neck immobilisation Sato, K.
 2016
 119 S1 p. S126-S127
2 p.
 artikel
1288 OC-0350: Post-radiation neuronal depletion in hippocampus measured by in-vivo magnetic resonance spectroscopy Pospisil, P.
 2016
 119 S1 p. S161-
1 p.
 artikel
1289 OC-0145: Preoperative radiotherapy with an integrated boost compared to chemoradiotherapy for rectal cancer De Ridder, M.
 2016
 119 S1 p. S66-
1 p.
 artikel
1290 OC-0136: Primary Study Endpoint Analysis of NRG Oncology/RTOG 0813 Trial of SBRT for centrally located NSCLC Bezjak, A.
 2016
 119 S1 p. S61-S62
2 p.
 artikel
1291 OC-0452: Prospective randomized adaptive dose-de-escalation in the elective neck: late toxicity and control Schatteman, J.
 2016
 119 S1 p. S211-S212
2 p.
 artikel
1292 OC-0157: Prostate fiducial markers detection with the use of multiparametric-MRI Fernandes, C.D.
 2016
 119 S1 p. S72-S73
2 p.
 artikel
1293 OC-0248: Proton Beam Therapy in childhood – First 2-years of practice results from the WPE Mazhari, A.L.
 2016
 119 S1 p. S113-S114
2 p.
 artikel
1294 OC-0245: Protontherapy for uveal melanomas of temporal superior Lanteri, S.
 2016
 119 S1 p. S112-S113
2 p.
 artikel
1295 OC-0055: Pseudo-progression after stereotactic radiotherapy of brain metastases is serious radiation toxicity Wiggenraad, R.
 2016
 119 S1 p. S23-S24
2 p.
 artikel
1296 OC-0465: Quality of treatment plans in hybrid IMRT and VMAT for prostate radiotherapy Bedford, J.
 2016
 119 S1 p. S219-S220
2 p.
 artikel
1297 OC-0097: Radiation dose-volume effects for liver SBRT Miften, M.
 2016
 119 S1 p. S45-
1 p.
 artikel
1298 OC-0046: Radiation induced carcinogenesis of cells with stem cell potential from breast and thyroid gland Zwar, M.
 2016
 119 S1 p. S19-
1 p.
 artikel
1299 OC-0151: Radiation induced toxicity and tumour control in pts treated for uveal melanoma with ru-106 plaques Espensen, C.A.
 2016
 119 S1 p. S69-
1 p.
 artikel
1300 OC-0609: Radiomic CT features for evaluation of EGFR and KRAS mutation status in patients with advanced NSCLC De Jong, E.E.C.
 2016
 119 S1 p. S290-S291
2 p.
 artikel
1301 OC-0420: Radiomics in OPSCC: a novel quantitative imaging biomarker for HPV status? Leijenaar, R.T.H.
 2016
 119 S1 p. S196-
1 p.
 artikel
1302 OC-0133: Radioresistance of glioblastoma stem-like cells is associated with replication stress Carruthers, R.
 2016
 119 S1 p. S60-
1 p.
 artikel
1303 OC-0234: Radiotherapy and L19-IL2: perfect match for an abscopal effect with long-lasting memory Rekers, N.H.
 2016
 119 S1 p. S106-S107
2 p.
 artikel
1304 OC-0443: Radiotherapy sensitivity in breast cancer is influenced by the DNA cytosine deaminase APOBEC3B Span, P.N.
 2016
 119 S1 p. S206-S207
2 p.
 artikel
1305 OC-0243: Randomised trial on preoperative platin-based Radiochemotherapy in rectal cancer: 10-years analysis Gambacorta, M.
 2016
 119 S1 p. S111-
1 p.
 artikel
1306 OC-0063: Real-time in-vivo dosimetry in HDR prostate brachytherapy Mason, J.
 2016
 119 S1 p. S27-S28
2 p.
 artikel
1307 OC-0209: Real-time liver motion monitoring on conventional linac by external surrogate and sparse kV imaging Bertholet, J.
 2016
 119 S1 p. S94-S95
2 p.
 artikel
1308 OC-0211: Real-time MRI-guided Radiotherapy for pancreatic cancer Rosenberg, S.A.
 2016
 119 S1 p. S96-
1 p.
 artikel
1309 OC-0053: Re- irradiation for locally recurrent breast cancer Bräutigam, E.
 2016
 119 S1 p. S22-S23
2 p.
 artikel
1310 OC-0054: Reirradiation+hyperthermia for recurrent breast canceren-cuirasse in previously irradiated area Oldenborg, S.
 2016
 119 S1 p. S23-
1 p.
 artikel
1311 OC-0553: Relative risks of radiation-induced secondary cancer following particle therapy of prostate cancer Stokkevåg, C.
 2016
 119 S1 p. S265-S266
2 p.
 artikel
1312 OC-0161: Renal and diaphragmatic interfractional motion in children and adults: is there a difference? Van Dijk, I.W.E.M.
 2016
 119 S1 p. S75-
1 p.
 artikel
1313 OC-0072: Respiratory time-resolved 4D MR imaging for RT applications with acquisition times below one minute Rank, C.M.
 2016
 119 S1 p. S33-
1 p.
 artikel
1314 OC-0545: Results of a national audit of IMRT and VMAT patient QA Seravalli, E.
 2016
 119 S1 p. S259-S260
2 p.
 artikel
1315 OC-0400: Risk estimation of cardiac toxicity following craniospinal irradiation of pediatric patients Engeseth, G.
 2016
 119 S1 p. S187-S188
2 p.
 artikel
1316 OC-0065: Risk of second malignancies after seed prostatebrachytherapy as monotherapy in a single institution Fernandez Ots, A.
 2016
 119 S1 p. S29-
1 p.
 artikel
1317 OC-0344: Risk of second primary cancers after radiotherapy for prostate cancer Hegemann, N.S.
 2016
 119 S1 p. S158-
1 p.
 artikel
1318 OC-0163: Robustness of proton RT with different beam angles towards inter-fractional motion in the pelvis Andersen, A.
 2016
 119 S1 p. S76-S77
2 p.
 artikel
1319 OC-0554: Robustness recipe for minimax robust optimisation in IMPT for oropharyngeal cancer patients Van der Voort, S.
 2016
 119 S1 p. S266-
1 p.
 artikel
1320 OC-0081: Robust photon versus robust proton therapy planning with a library of plans for cervical cancer Crama, K.
 2016
 119 S1 p. S38-
1 p.
 artikel
1321 OC-0244: Similar quality of life after short-course radiation versus chemoradiation in rectal cancer patients Couwenberg, A.M.
 2016
 119 S1 p. S112-
1 p.
 artikel
1322 OC-0361: Simulation of clinical relevance errors detected by real-time EPID-based patient verification system Fuangrod, T.
 2016
 119 S1 p. S167-
1 p.
 artikel
1323 OC-0552: Skin-NTCP driven optimization for breast proton treatment plans Cella, L.
 2016
 119 S1 p. S264-S265
2 p.
 artikel
1324 OC-0459: Small fields output factors and correction factors determination for a linac with circular cones Girardi, A.
 2016
 119 S1 p. S216-
1 p.
 artikel
1325 OC-0259: Spatial rectal dose-response for patient-reported leakage, obstruction, and urgency in prostate RT Casares-Magaz, O.
 2016
 119 S1 p. S119-S120
2 p.
 artikel
1326 OC-0539: Stage II testicular seminoma: patterns of care and survival by treatment strategy Glaser, S.M.
 2016
 119 S1 p. S255-S256
2 p.
 artikel
1327 OC-0444: Stereotactic body radiotherapy of hepatocellular carcinoma lesions in liver transplant candidates Shiao, J.
 2016
 119 S1 p. S207-
1 p.
 artikel
1328 OC-0447: Stereotactic Body Radiotherapy (SBRT) in oligometastatic prostate cancer patients Chaw, C.L.
 2016
 119 S1 p. S209-
1 p.
 artikel
1329 OC-0359: Superficial dose verification of four dose calculation algorithms Cao, Y.
 2016
 119 S1 p. S166-
1 p.
 artikel
1330 OC-0358: Surface doses with FFF VMAT dose delivery for breast cancer Seppala, J.
 2016
 119 S1 p. S165-S166
2 p.
 artikel
1331 OC-0239: Survival of clinical stage I-III rectal cancer patients: a population-based comparison Joye, I.
 2016
 119 S1 p. S108-S109
2 p.
 artikel
1332 OC-0543: Technical development and clinical implementation of an MR-guided radiation therapy environment Stanescu, T.
 2016
 119 S1 p. S258-S259
2 p.
 artikel
1333 OC-0533: TGUGT and G8 tests predicting frailty and radiotherapy compliance and acute toxicity in the elderly Middelburg, J.
 2016
 119 S1 p. S252-
1 p.
 artikel
1334 OC-0546: The development of proton-beam grid therapy (PBGT) Henry, T.
 2016
 119 S1 p. S260-S261
2 p.
 artikel
1335 OC-0415: The effect of breathing motion on CT radiomics feature extraction in oesophageal cancer Larue, R.T.H.M.
 2016
 119 S1 p. S193-
1 p.
 artikel
1336 OC-0549: The effects of a magnetic field and real-time tumor tracking on lung stereotactic body radiotherapy Menten, M.J.
 2016
 119 S1 p. S262-S263
2 p.
 artikel
1337 OC-0352: The high doses employed in brachytherapy of cervical cancer counteract hypoxia – a modelling study Lindblom, E.
 2016
 119 S1 p. S162-
1 p.
 artikel
1338 OC-0559: The impact of rectal interventions on target motion and rectal variability in prostate radiotherapy Smith, C.
 2016
 119 S1 p. S268-S269
2 p.
 artikel
1339 OC-0166: The influence of tumour location in the breast on boost modality selection Reilly, E.
 2016
 119 S1 p. S78-
1 p.
 artikel
1340 OC-0370: The influence of virtual training on pelvic radiotherapy education for the multidisciplinary team Williams, A.
 2016
 119 S1 p. S172-S173
2 p.
 artikel
1341 OC-0365: The need for anatomical landmarks in adaptive rectal cancer boost radiotherapy Kleijnen, J.J.E.
 2016
 119 S1 p. S169-S170
2 p.
 artikel
1342 OC-0146: The PROS-IT CNR study: comorbidities and medications at the time of diagnosis of prostate cancer Magrini, S.
 2016
 119 S1 p. S66-S67
2 p.
 artikel
1343 OC-0531: Time driven activity based costing: a conceptual framework for cost assessment in radiation therapy Defourny, N.
 2016
 119 S1 p. S251-
1 p.
 artikel
1344 OC-0360: TomoTherapy tangential breast treatment position uncertainty via exit detector fluence Corradini, N.
 2016
 119 S1 p. S166-S167
2 p.
 artikel
1345 OC-0457: Towards analytic dose calculation for MR guided particle beam therapy Fuchs, H.
 2016
 119 S1 p. S214-S215
2 p.
 artikel
1346 OC-0076: Towards MR-Linac dosimetry: B-field effects on ionchamber measurements in a Co-60 beam Agnew, J.
 2016
 119 S1 p. S35-
1 p.
 artikel
1347 OC-0213: Towards on-line sub-mm and sub-second positional verification during stereotactic spine radiotherapy Hazelaar, C.
 2016
 119 S1 p. S97-
1 p.
 artikel
1348 OC-0547: Towards Portal Dosimetry for the MR-linac: back-projection algorithm in the presence of MRI scanner Torres Xirau, I.
 2016
 119 S1 p. S261-
1 p.
 artikel
1349 OC-0456: Translation of a prompt gamma based proton range verification system to first clinical application Richter, C.
 2016
 119 S1 p. S214-
1 p.
 artikel
1350 OC-0049: Trends in the use of postoperative radiotherapy following mastectomy: a population-based study Corradini, S.
 2016
 119 S1 p. S20-S21
2 p.
 artikel
1351 OC-0348: Tumor bed radiosurgery vs. whole brain radiotherapy after surgery of single brain metastasis Kepka, L.
 2016
 119 S1 p. S160-
1 p.
 artikel
1352 OC-0048: Tumor microenvironment response and bone marrow cell migration after pulsed radiotherapy Kane, J.L.
 2016
 119 S1 p. S20-
1 p.
 artikel
1353 OC-0538: Tumor-related leukocytosis associated with poor radiation response and outcome in cervical cancer Cho, Y.
 2016
 119 S1 p. S255-
1 p.
 artikel
1354 OC-0137: Tumour size but not location determines survival and control of lung stereotactic body radiotherapy Roach, M.
 2016
 119 S1 p. S62-
1 p.
 artikel
1355 OC-0451: Tumour volume, hypoxia and cancer stem cells as prognosticators for LRC after primary RCT in HNSCC Linge, A.
 2016
 119 S1 p. S211-
1 p.
 artikel
1356 OC-0374: Use of IV contrast media in pre-treatment radiotherapy planning CT scans: A UK study Williams, K.
 2016
 119 S1 p. S174-S175
2 p.
 artikel
1357 OC-0069: Using texture analysis to detect prostate cancer for automated outlining and adaptive radiotherapy Welsh, D.
 2016
 119 S1 p. S31-
1 p.
 artikel
1358 OC-0468: Validation of Mask Based Registration in CBCT pretreatment imaging of locally advanced cervix ca Van den Berghe, L.
 2016
 119 S1 p. S221-S222
2 p.
 artikel
1359 OC-0051: Variability in lymph node delineation for breast cancer radiotherapy: an AIRO multicenter study Ciardo, D.
 2016
 119 S1 p. S21-S22
2 p.
 artikel
1360 OC-0050: Variations in use of hypofractionation for early, node-negative breast cancer in NSW 2007-2012 Delaney, G.
 2016
 119 S1 p. S21-
1 p.
 artikel
1361 OC-0369: Video glasses to reduce claustrophobic anxiety in radiotherapy treatment Althof, V.
 2016
 119 S1 p. S172-
1 p.
 artikel
1362 OC-0246: Visual outcomes of parapapillary uveal melanomas following proton beam therapy Thariat, J.
 2016
 119 S1 p. S113-
1 p.
 artikel
1363 OC-0263: VMAT plus few optimized non-coplanar IMRT beams is equivalent to multi-beam non-coplanar liver SBRT Sharfo, A.W.M.
 2016
 119 S1 p. S122-S123
2 p.
 artikel
1364 OC-0083: When using gating in left tangential breast irradiation? A planning decision tool Dinapoli, N.
 2016
 119 S1 p. S39-S40
2 p.
 artikel
1365 OC-0159: X-ray tube current modulation with dynamic blade collimation for CBCT guidance Parsons, D.
 2016
 119 S1 p. S73-S74
2 p.
 artikel
1366 Patient-specific motion management and adaptive respiratory gating in Pancreatic SBRT Jones, B.L.
 2016
 119 S1 p. S151-
1 p.
 artikel
1367 PO-0882: Abdominal organ motion during breath-hold measured in volunteers on MRI: inhale and exhale compared Lens, E.
 2016
 119 S1 p. S422-S423
2 p.
 artikel
1368 PO-1006: A breath-hold friendly, hybrid 3DCRT/IMRT technique for locoregional breast irradiation Hunnego, K.
 2016
 119 S1 p. S487-S488
2 p.
 artikel
1369 PO-0787: Abstract withdrawn 2016
 119 S1 p. S370-
1 p.
 artikel
1370 PO-0821: A comparison between different patient QA devices for IMRT treatments on VERO system Bazani, A.
 2016
 119 S1 p. S388-
1 p.
 artikel
1371 PO-1002: A comparison of outcomes using VMAT and 3DCRT in treatment of esophageal cancer Jimenez-Jimenez, E.
 2016
 119 S1 p. S486-
1 p.
 artikel
1372 PO-0948: A comprehensive evaluation of intracranial SRS treatment accuracy Van de Water, T.A.
 2016
 119 S1 p. S460-S461
2 p.
 artikel
1373 PO-0981: Activation of immune cells and enhanced efficacy of radiotherapy by anti-TIP1 antibodies in cancer Hallahan, D.
 2016
 119 S1 p. S477-
1 p.
 artikel
1374 PO-0638: Adaptive dose painting by numbers for head and neck cancer: interim analysis of a randomised trial Duprez, F.
 2016
 119 S1 p. S298-S299
2 p.
 artikel
1375 PO-1013: Adaptive radiotherapy in prostate cancer patients: concepts for Individualized Radiotherapy (iRT) Fuchs, F.
 2016
 119 S1 p. S491-
1 p.
 artikel
1376 PO-0772: Adequacy of dose volume constraints in stereotactic radiotherapy and radiosurgery of abdominal area Cilla, S.
 2016
 119 S1 p. S362-S363
2 p.
 artikel
1377 PO-0914: Adjustment of CT calibration in presence of titanium implants by pencil beam proton radiography Righetto, R.
 2016
 119 S1 p. S441-S442
2 p.
 artikel
1378 PO-0962: Adjuvant brachytherapy as a part of a multimodal treatment for high-grade uterine sarcoma Annède, P.
 2016
 119 S1 p. S468-
1 p.
 artikel
1379 PO-0758: Adjuvant or Salvage?10-y results of the AIRO Group on Prostate cancer multicentre prospective trial Maurizi, F.
 2016
 119 S1 p. S354-S355
2 p.
 artikel
1380 PO-0724: Adjuvant SIB-VMAT in endometrial cancer: a dose escalation study Macchia, G.
 2016
 119 S1 p. S339-
1 p.
 artikel
1381 PO-0708: Advanced age is no contraindication for chemoradiotherapy with curative intent in oesophageal cancer Voncken, F.
 2016
 119 S1 p. S330-
1 p.
 artikel
1382 PO-0797: Advanced Radiation Dosimetry System (ARDOS) - A novel breathing phantom for radiation therapy Kostiukhina, N.
 2016
 119 S1 p. S375-S376
2 p.
 artikel
1383 PO-0868: A method to define isodose-based structures in Dose Painting treatment of GBM in Tomotherapy Orlandi, M.
 2016
 119 S1 p. S414-S415
2 p.
 artikel
1384 PO-0632: A multivariate model predicting grade ≥ 2 neck fibrosis at 6 months after radio(chemo)therapy Nevens, D.
 2016
 119 S1 p. S295-S296
2 p.
 artikel
1385 PO-0819: Analysis of liquid embolic agents on flattening filter free dose deposition with Monte Carlo method Akcay, D.
 2016
 119 S1 p. S387-
1 p.
 artikel
1386 PO-0780: An analysis of elderly patients compliance and disease distribution treated with radiation therapy Lee, S.H.
 2016
 119 S1 p. S367-
1 p.
 artikel
1387 PO-0946: A new liquid fiducial marker formulation for image-guided pencil beam scanning proton radiotherapy Scherman Rydhög, J.
 2016
 119 S1 p. S459-S460
2 p.
 artikel
1388 PO-0973: A novel approach to locating source dwell positions in HDR brachytherapy gynaecological applicators Franich, R.
 2016
 119 S1 p. S473-S474
2 p.
 artikel
1389 PO-0692: A novel endoscopically injected liquid-gel marker for image guided radiotherapy of thoracic tumours Mortensen, S.R.
 2016
 119 S1 p. S323-S324
2 p.
 artikel
1390 PO-0985: Anti-GRP 78 antibodies bind specifically to cancers enhance efficacy of radiotherapy in cancer Dadey, D.
 2016
 119 S1 p. S478-S479
2 p.
 artikel
1391 PO-0864: A planning study investigating different planning techniques for SBRT of NSCLC Moustakis, C.
 2016
 119 S1 p. S412-S413
2 p.
 artikel
1392 PO-0922: Are planning CT radiomics and cone-beam CT radiomics interchangeable? Van Timmeren, J.E.
 2016
 119 S1 p. S446-S447
2 p.
 artikel
1393 PO-0813: Assessing the quality of proton PBS delivery: log file analysis of every treatment at PSI Gantry 2 Scandurra, D.
 2016
 119 S1 p. S384-
1 p.
 artikel
1394 PO-0994: Assessment of [11C]-metformin PET for identification of patients suitable for metformin treatment Iversen, A.
 2016
 119 S1 p. S482-S483
2 p.
 artikel
1395 PO-0892: Assessment of respiratory and cardiac motion to supplement MRI based tracking of hilar lymph nodes Canjels, L.P.W.
 2016
 119 S1 p. S429-
1 p.
 artikel
1396 PO-0835: A system for measuring and calculating neutron doses in paediatric proton patients Schulte, R.
 2016
 119 S1 p. S395-S396
2 p.
 artikel
1397 PO-0956: Audit of 100 consecutive cervical cancer patients treated with HDR CT guided brachytherapy Zahra, M.
 2016
 119 S1 p. S465-
1 p.
 artikel
1398 PO-0949: Automated approval of a pre trial benchmark RTTQA case. The ARISTOTLE experience Sweeney, L.N.
 2016
 119 S1 p. S461-S462
2 p.
 artikel
1399 PO-0837: Automatic treatment planning improves clinical quality of Head and Neck cancer treatments Hansen, C.R.
 2016
 119 S1 p. S396-S397
2 p.
 artikel
1400 PO-0877: Baseline CT image and isodose shape features improve prognostic models for dyspnea after RT in NSCLC Defraene, G.
 2016
 119 S1 p. S420-
1 p.
 artikel
1401 PO-0814: Beam quality and perturbation factors of Farmer chambers in magnetic fields Spindeldreier, C.K.
 2016
 119 S1 p. S384-S385
2 p.
 artikel
1402 PO-0799: Beam quality specifiers for an integrated MRI-linac O'Brien, D.J.
 2016
 119 S1 p. S376-S377
2 p.
 artikel
1403 PO-0826: Benchmarking computed IDD curves for four proton treatment planning systems against measured data Alshaikhi, J.
 2016
 119 S1 p. S391-
1 p.
 artikel
1404 PO-0904: Bladder changes assessment using daily cone-beam computed tomography Casares-Magaz, O.
 2016
 119 S1 p. S435-S436
2 p.
 artikel
1405 PO-0952: Blended teaching reduces interobserver contouring variability: first results of the FALCON project De Bari, B.
 2016
 119 S1 p. S463-
1 p.
 artikel
1406 PO-0634: Body image in irradiated head and neck cancer patients Chiu, H.
 2016
 119 S1 p. S296-S297
2 p.
 artikel
1407 PO-0927: Bone texture analysis as predictive of bone radiation damage in patients undergoing pelvic RT Nardone, V.
 2016
 119 S1 p. S449-
1 p.
 artikel
1408 PO-0885: Brain motion induced artefacts in microbeam radiation therapy: a Monte Carlo study Donzelli, M.
 2016
 119 S1 p. S425-
1 p.
 artikel
1409 PO-0834: Calibrating absolute malignant induction probabilities into life-time attributable risk Madkhali, A.
 2016
 119 S1 p. S395-
1 p.
 artikel
1410 PO-1012: Can we adequately irradiate bladder cancer without daily on line adaptive treatment? Noordermeer, J.
 2016
 119 S1 p. S490-S491
2 p.
 artikel
1411 PO-0934: Cardio-respiratory motion compensation for 5D thoracic CBCT in IGRT Sauppe, S.
 2016
 119 S1 p. S452-S453
2 p.
 artikel
1412 PO-0817: Characteristics and performance of the first commercial MLC for a robotic delivery system Prins, P.
 2016
 119 S1 p. S386-
1 p.
 artikel
1413 PO-0825: Characterization of a commercial EPID 3d software for in vivo dosimetry Esposito, M.
 2016
 119 S1 p. S390-S391
2 p.
 artikel
1414 PO-0715: Chemoradiation with concomitant boost in rectal cancer (T4&recurrences): a phase II study Picardi, V.
 2016
 119 S1 p. S335-
1 p.
 artikel
1415 PO-0756: Choline PET/CT and Stereotactic Body Radiotherapy in oligometastatic prostate cancer patients Pasqualetti, F.
 2016
 119 S1 p. S353-S354
2 p.
 artikel
1416 PO-0856: Clinical and dosimetric issues of VMAT craniospinal irradiation for paediatric medulloblastoma Meroni, S.
 2016
 119 S1 p. S408-
1 p.
 artikel
1417 PO-0972: Clinical application and validation of a collapsed cone based algorithm for brachytherapy Guemnie Tafo, A.
 2016
 119 S1 p. S472-S473
2 p.
 artikel
1418 PO-0804: Clinical applications of a Monte Carlo tool of a proton pencil beam scanning delivery system Fracchiolla, F.
 2016
 119 S1 p. S379-S380
2 p.
 artikel
1419 PO-0891: Clinical implementation and experience with real-time anatomy tracking and gating during MR-IGRT Green, O.
 2016
 119 S1 p. S428-S429
2 p.
 artikel
1420 PO-0880: Clinical implementation of 5DCT workflow Low, D.
 2016
 119 S1 p. S422-
1 p.
 artikel
1421 PO-0913: Clinically applicable T2-weighted 4D Magnetic Resonance Imaging with good abdominal contrast Tekelenburg, D.
 2016
 119 S1 p. S440-S441
2 p.
 artikel
1422 PO-0705: Clinical outcomes for inoperable HCC treated with SBRT: results on 71 patients and 102 lesions Comito, T.
 2016
 119 S1 p. S329-
1 p.
 artikel
1423 PO-0839: Clinical simulation of nodal boosting in cervix cancer using reduced margin and coverage probability Ramlov, A.
 2016
 119 S1 p. S398-
1 p.
 artikel
1424 PO-0984: Combined inhibition of Chk1 and Wee1 kinases for cancer treatment Hauge, S.
 2016
 119 S1 p. S478-
1 p.
 artikel
1425 PO-0988: Combined treatment strategies for microtubule interfering agent-resistant tumors Broggini-Tenzer, A.
 2016
 119 S1 p. S479-S480
2 p.
 artikel
1426 PO-0673: Common European mitochondrial haplogroups in the risk of RT-induced breast fibrosis Deantonio, L.
 2016
 119 S1 p. S314-
1 p.
 artikel
1427 PO-0677: Comparing detailed cardiac structure dose-volume metrics in supine versus prone breast irradiation Luo, C.
 2016
 119 S1 p. S315-S316
2 p.
 artikel
1428 PO-0923: Comparing FMISO and FDG positive tumour sub-volumes for PET-based dose escalation in SCCHN Mönnich, D.
 2016
 119 S1 p. S447-
1 p.
 artikel
1429 PO-0666: Comparing the efficacy of low-dose radiotherapy in patients with aggressive and indolent lymphomas Furlan, C.
 2016
 119 S1 p. S311-
1 p.
 artikel
1430 PO-0869: Comparing Varian EDGE and Gamma Knife for brain metastases radiosurgery. Preliminary results Tomatis, S.
 2016
 119 S1 p. S415-S416
2 p.
 artikel
1431 PO-0897: Comparison of hippocampus sparing extent according to the tilt of a patient head during WBRT Moon, S.
 2016
 119 S1 p. S432-S433
2 p.
 artikel
1432 PO-0862: Comparison of Monte-Carlo computed 50 kV X-rays radiation therapy and EBRT for rectal cancer Vidal, M.
 2016
 119 S1 p. S411-S412
2 p.
 artikel
1433 PO-0679: Comparison of toxicity and outcome in stage III NSCLC patients treated with IMRT or VMAT Wiisman, R.
 2016
 119 S1 p. S317-
1 p.
 artikel
1434 PO-0665: Compliance with ILROG guidelines in the treatment of extranodal lymphomas; an internal plans review Furlan, C.
 2016
 119 S1 p. S310-
1 p.
 artikel
1435 PO-0713: Conformity analysis of target-volume definition for margin-directed boost in pancreatic cancer SBRT Holyoake, D.
 2016
 119 S1 p. S333-S334
2 p.
 artikel
1436 PO-0750: Conventionally-fractionated VMAT vs. SBRT in prostate cancer:PSA kinetics, toxicity,quality of life Tambas, M.
 2016
 119 S1 p. S350-S351
2 p.
 artikel
1437 PO-0935: Correcting diffusion weighted MR images for signal pile-up and distortions near gas pockets Van Buuren, L.D.
 2016
 119 S1 p. S453-
1 p.
 artikel
1438 PO-0830: Correlation of MLC positions detected using log-files with MLC positions detected using the EPID Lechner, W.
 2016
 119 S1 p. S393-
1 p.
 artikel
1439 PO-0786: Could a 3-tier teleradiotherapy network provide a cost-effective radiotherapy care in LMICs? Datta, N.R.
 2016
 119 S1 p. S370-
1 p.
 artikel
1440 PO-0841: Cranial stereotactic trajectory optimization via patient-specific overlap atlas MacDonald, L.
 2016
 119 S1 p. S399-S400
2 p.
 artikel
1441 PO-0967: Current practice in quality assurance of the Papillon50 contact X-ray brachytherapy system in the UK Humbert-Vidan, L.
 2016
 119 S1 p. S470-
1 p.
 artikel
1442 PO-0807: 3D and 4D dose calculations for tumour-tracking irradiation of lung/liver tumours using gimbaled linac Iizuka, Y.
 2016
 119 S1 p. S381-
1 p.
 artikel
1443 PO-0829: Determining the mechanical properties of a radiochromic deformable silicone-based 3D dosimeter Kaplan, L.P.
 2016
 119 S1 p. S392-S393
2 p.
 artikel
1444 PO-0865: Developing sciatic nerve-sparing stereotactic radiotherapy for re-irradiating the pelvic sidewall Llewelyn, M.
 2016
 119 S1 p. S413-
1 p.
 artikel
1445 PO-0968: Development of a fluorescent screen based QA system for dose verification of afterloading HDR unit Chiu, T.L.
 2016
 119 S1 p. S470-S471
2 p.
 artikel
1446 PO-0851: Development of a postoperative image-based treatment planning system for breast IOERT Baghani, H.R.
 2016
 119 S1 p. S405-S406
2 p.
 artikel
1447 PO-0969: Development of dose measurements close to brachytherapy sources in the German standard DIN 6803 Hensley, F.
 2016
 119 S1 p. S471-
1 p.
 artikel
1448 PO-0858: Development of dysphagia optimised IMRT for head and neck cancer treatment in the DARS trial Tyler, J.
 2016
 119 S1 p. S409-S410
2 p.
 artikel
1449 PO-0893: Direct comparison of electromagnetic guided couch and MLC tracking on a TrueBeam accelerator Hansen, R.
 2016
 119 S1 p. S429-S430
2 p.
 artikel
1450 PO-0792: Direct dose measurements in contrast enhanced radiotherapy with iodine and gadolinium Cherepanov, A.A.
 2016
 119 S1 p. S372-S373
2 p.
 artikel
1451 PO-0633: Dissection of submandibular glands increases the risk of xerostomia after postoperative radiotherapy Van der Laan, H.P.
 2016
 119 S1 p. S296-
1 p.
 artikel
1452 PO-0996: Distinct radiation responses after mtDNA depletion are potentially related to oxidative stress Van Gisbergen, M.W.
 2016
 119 S1 p. S483-S484
2 p.
 artikel
1453 PO-0678: Do blood-biomarkers enhance clinical models for NSCLC patients treated with radical radiotherapy? Carvalho, S.
 2016
 119 S1 p. S316-S317
2 p.
 artikel
1454 PO-0831: Does a single MLC characterization guarantee a high accuracy of RapidArc delivered dose? Scaggion, A.
 2016
 119 S1 p. S393-S394
2 p.
 artikel
1455 PO-0767: Does fluid collection have an impact on radiotherapy outcomes after excision of soft tissue sarcoma? Choi, N.
 2016
 119 S1 p. S359-
1 p.
 artikel
1456 PO-1003: Does level of DIBH amplitude correlate to reduction in cardiac dose in left breast cancer patients? Ledsom, D.
 2016
 119 S1 p. S486-S487
2 p.
 artikel
1457 PO-0886: Does lung capacity influence the geometrical reproducibility in DIBH radiotherapy of NSCLC patients? Sibolt, P.
 2016
 119 S1 p. S425-S426
2 p.
 artikel
1458 PO-0657: Does Radiomics have prognostic value in glioblastoma? Compter, I.
 2016
 119 S1 p. S306-S307
2 p.
 artikel
1459 PO-0684: Does the dose to heart affect survival in NSCLC patient treated with definitive Radiotherapy? Schytte, T.
 2016
 119 S1 p. S319-S320
2 p.
 artikel
1460 PO-0966: Dose planning of intraluminal brachytherapy for esophageal cancer using MR imaging Reci, R.
 2016
 119 S1 p. S469-S470
2 p.
 artikel
1461 PO-0874: Dose prescription in carbon ion radiotherapy: how to compare different RBE-weighted dose systems Molinelli, S.
 2016
 119 S1 p. S418-S419
2 p.
 artikel
1462 PO-0796: Dose rate dependence of the PTW 60019 microDiamond detector in high dose-per-pulse pulsed beams Pardo-Montero, J.
 2016
 119 S1 p. S375-
1 p.
 artikel
1463 PO-0701: Dose-response relationship for locoregional control in esophageal cancer treated with curative CRT Kim, H.J.
 2016
 119 S1 p. S327-
1 p.
 artikel
1464 PO-0635: Dose to the masseter muscle and risk of trismus after chemoradiation for advanced head & neck cancer Verheijen, S.
 2016
 119 S1 p. S297-
1 p.
 artikel
1465 PO-0795: Dose verification of fast and continuous scanning in proton therapy Klimpki, G.
 2016
 119 S1 p. S374-S375
2 p.
 artikel
1466 PO-0762: Dose-volume predictors of radio-induced effects after SRS for uveal melanoma Gigliotti, C.R.
 2016
 119 S1 p. S357-
1 p.
 artikel
1467 PO-0812: Dosimetric accuracy of TPS algorithms for actively scanned proton beams and small target volumes Magro, G.
 2016
 119 S1 p. S384-
1 p.
 artikel
1468 PO-0844: Dosimetrical advantages of 4D mid-vent: should every LA NSCLC patient be treated this way? Philippi, S.
 2016
 119 S1 p. S401-S402
2 p.
 artikel
1469 PO-0900: Dosimetric analysis of organ deformation during prostate IMAT with cone beam CT imaging Foley, D.
 2016
 119 S1 p. S433-S434
2 p.
 artikel
1470 PO-0828: Dosimetric assessment of a second generation Multi-Leaf Collimator for robotic radiotherapy Mackeprang, P.H.
 2016
 119 S1 p. S391-S392
2 p.
 artikel
1471 PO-1005: Dosimetric effect of US versus CT delineation on postplanning I-125 treatment Van der Klein, J.
 2016
 119 S1 p. S487-
1 p.
 artikel
1472 PO-0843: Dosimetric evaluation of 10 years of treatment planning improvements in head and neck cancer Tol, J.
 2016
 119 S1 p. S400-S401
2 p.
 artikel
1473 PO-1001: Dosimetric impact of flattening filter and flattening filter-free beams on IMRT planning of NSCLC Lee, S.W.Y.
 2016
 119 S1 p. S485-S486
2 p.
 artikel
1474 PO-0959: Dosimetric outcome and perioperative toxicity using Utrecht applicator in cervical brachytherapy Celada Alvarez, F.J.
 2016
 119 S1 p. S466-S467
2 p.
 artikel
1475 PO-0941: 3D printed bolus for chestwall radiation therapy Robar, J.
 2016
 119 S1 p. S456-S457
2 p.
 artikel
1476 PO-0760: 3D Radiotherapy with concurrent weekly Gemcitabine and Cisplatin for bladder carcinoma Varveris, A.
 2016
 119 S1 p. S356-
1 p.
 artikel
1477 PO-0929: Dual Energy CT imaging of tumour vasculature in NSCLC: an intra-patient comparison with DCE-CT Even, A.J.G.
 2016
 119 S1 p. S450-
1 p.
 artikel
1478 PO-0943: Dutch national head and neck plan comparison significantly improved treatment planning quality Verbakel, W.
 2016
 119 S1 p. S457-S458
2 p.
 artikel
1479 PO-0920: Early prediction of individual response in neo-adjuvant adaptive Radiochemotherapy for rectal cancer Raso, R.
 2016
 119 S1 p. S445-S446
2 p.
 artikel
1480 PO-0954: Early results of a multi-center trial of IORT using electronic brachytherapy for breast cancer Costa, P.
 2016
 119 S1 p. S464-
1 p.
 artikel
1481 PO-0963: Effectiveness of week 5 MRI virtual preplanning for Image-Guided Brachytherapy for cervical cancers Chang, A.
 2016
 119 S1 p. S468-
1 p.
 artikel
1482 PO-0907: Effect of weight loss in head and neck patients in the presence of a magnetic field McWilliam, A.
 2016
 119 S1 p. S437-
1 p.
 artikel
1483 PO-1000: Effect of X-rays and carbon ions on cell survival and expression of Hh pathway genes in cancer cells Konings, K.
 2016
 119 S1 p. S485-
1 p.
 artikel
1484 PO-0744: Effects of IMRT or radical prostatectomy (RP) on serum testosterone in patients with prostate cancer Marin, A. Giraldo
 2016
 119 S1 p. S347-S348
2 p.
 artikel
1485 PO-0670: Efficacy of low dose radiotherapy in relapsed or refractory Brady, J.L.
 2016
 119 S1 p. S312-S313
2 p.
 artikel
1486 PO-0748: Escalated-dose IMRT for prostate cancer: long-term toxicity and biochemical outcomes Bettina, H.
 2016
 119 S1 p. S349-
1 p.
 artikel
1487 PO-0938: Estimation of system-related geometric distortion in 7T MRI using a 3D anthropomorphic head phantom Peerlings, J.
 2016
 119 S1 p. S455-
1 p.
 artikel
1488 PO-0845: Evaluating dosimetric indices in lung SBRT for establishing treatment plan quality guidelines Yaparpalvi, R.
 2016
 119 S1 p. S402-
1 p.
 artikel
1489 PO-0854: Evaluation of a dedicated brain metastases treatment planning optimization for radiosurgery Gevaert, T.
 2016
 119 S1 p. S407-
1 p.
 artikel
1490 PO-0915: Evaluation of a metal artifact reduction algorithm for radiotherapy CT scans Rechner, L.
 2016
 119 S1 p. S442-S443
2 p.
 artikel
1491 PO-0894: Evaluation of daily setup errors in VMAT for craniospinal irradiation of paediatric patients Constantinescu, C.
 2016
 119 S1 p. S430-S431
2 p.
 artikel
1492 PO-0649: Evaluation of distant brain failure among patients undergoing SRS for lung cancer brain metastases Bhattal, G.
 2016
 119 S1 p. S303-S304
2 p.
 artikel
1493 PO-0660: Evaluation of distant brain failure among patients undergoing SRS for melanoma brain metastases Kailas, S.
 2016
 119 S1 p. S308-
1 p.
 artikel
1494 PO-0768: Evaluation of RT practice for limb soft tissue sarcomas and its impact on prognosis and toxicity Llacer-Moscardo, C.
 2016
 119 S1 p. S359-S360
2 p.
 artikel
1495 PO-0777: Evaluation of spinal stability in relation to pain response after radiotherapy for spinal metastases Gerlich, A.S.
 2016
 119 S1 p. S365-
1 p.
 artikel
1496 PO-0866: Evaluation of three planning RT techniques for boost phase in pediatric medulloblastomas Figueira, A.R.
 2016
 119 S1 p. S413-S414
2 p.
 artikel
1497 PO-0741: Even high-dose radiotherapy requires long-term androgen ablation for high-risk prostate cancer Nam, T.K.
 2016
 119 S1 p. S346-
1 p.
 artikel
1498 PO-0936: Evolved Grow-cut: A PET based segmentation algorithm for heterogeneous tumors Thevarthundiyil, H.M.T.
 2016
 119 S1 p. S453-S454
2 p.
 artikel
1499 PO-0975: External beam radiotherapy with HDR brachytherapy boost in prostate cancer: 5- and 8-year results Soumarova, R.
 2016
 119 S1 p. S474-
1 p.
 artikel
1500 PO-0774: Extra-cranial radiosurgery in oligometastatic disease: a dose escalation study (Destroy-2) Deodato, F.
 2016
 119 S1 p. S363-S364
2 p.
 artikel
1501 PO-0674: Factors influencing patient reported cosmetic outcome: results of the Young Boost Trial Brouwers, P.
 2016
 119 S1 p. S314-S315
2 p.
 artikel
1502 PO-0749: Factors predicting late severe urinary incontinence after postprostatectomy RT: a longitudinal study Chiorda, B. Noris
 2016
 119 S1 p. S349-S350
2 p.
 artikel
1503 PO-0645: 18F-FET PET and MRI for treatment planning in glioblastoma Harat, M.
 2016
 119 S1 p. S302-
1 p.
 artikel
1504 PO-0809: FFF beams from TrueBeam and Versa HD units: evaluation of the parameters for quality assurance Fogliata, A.
 2016
 119 S1 p. S382-S383
2 p.
 artikel
1505 PO-0794: First proton irradiation experiments with a deformable radiochromic 3D dosimeter Høye, E.M.
 2016
 119 S1 p. S373-S374
2 p.
 artikel
1506 PO-0870: Fitting data of relapse-free survival after postprostatectomy RT with a comprehensive TCP model Fiorino, C.
 2016
 119 S1 p. S416-
1 p.
 artikel
1507 PO-0823: Five-year results of treatment quality assurance using in vivo dosimetry in ocular proton therapy Caceres, A. Carnicer
 2016
 119 S1 p. S389-
1 p.
 artikel
1508 PO-0855: Flattening Filter Free VMAT for extreme hypofractionation of prostate cancer Ahlström, M.
 2016
 119 S1 p. S407-S408
2 p.
 artikel
1509 PO-0957: Focal boost to GTV in interstitial and intracavitary cervical brachytherapy - a feasibility study Groom, N.
 2016
 119 S1 p. S465-S466
2 p.
 artikel
1510 PO-0921: Free-breathing dynamic contrast enhanced MRI of lung cancer Kumar, S.
 2016
 119 S1 p. S446-
1 p.
 artikel
1511 PO-0800: Fricke-type dosimetry for “real-time” 3D dose measurements using MR-guided RT: a feasibility study Lee, H.J.
 2016
 119 S1 p. S377-S378
2 p.
 artikel
1512 PO-0993: Genetic profiles of glioblastoma in proximity to the subventricular zone receiving chemoradiation Adeberg, S.
 2016
 119 S1 p. S482-
1 p.
 artikel
1513 PO-0661: Gliosarcoma: prognostic and therapeutics factors Castelli, J.
 2016
 119 S1 p. S308-S309
2 p.
 artikel
1514 PO-0639: Graves ophthalmopathy: a network meta-analysis of treatments Shaikh, M.P.
 2016
 119 S1 p. S299-S300
2 p.
 artikel
1515 PO-0857: GTV-based prescription and Monte Carlo treatment planning in Cyberknife treatments for lung lesions Vai, A.
 2016
 119 S1 p. S408-S409
2 p.
 artikel
1516 PO-0976: HDR prostate brachytherapy: 3-D planned simultaneous integrated boost to the peripheral zone Hepp, R.
 2016
 119 S1 p. S475-
1 p.
 artikel
1517 PO-0849: Heart structures sparing through volumetric modulated arc therapy in mediastinal Hodgkin lymphoma Filippi, A.R.
 2016
 119 S1 p. S404-S405
2 p.
 artikel
1518 PO-0729: Hematological toxicity of Rth-Chth for cervical cancer: Rth technique and dose given to bone marrow Bialas, K.
 2016
 119 S1 p. S341-
1 p.
 artikel
1519 PO-0964: High-dose-rate interstitial brachytherapy as monotherapy for locally limited mobile tongue cancer Yoshida, K.
 2016
 119 S1 p. S469-
1 p.
 artikel
1520 PO-0720: High tumour glycine concentration - an adverse prognostic factor in locally advanced rectal cancer Redalen, K.
 2016
 119 S1 p. S337-
1 p.
 artikel
1521 PO-0644: Hippocampal sparing brain radiotherapy using VMAT to the primary brain tumour Kim, K.S.
 2016
 119 S1 p. S301-S302
2 p.
 artikel
1522 PO-0924: Histogram analysis of ADCs from DWMRI predicts tumour response and survival for rectal cancer Bakke, K.
 2016
 119 S1 p. S447-S448
2 p.
 artikel
1523 PO-0890: Homogeneous versus inhomogeneous dose prescription in liver SBRT: effect on delivered CTV-dose Hansen, A.T.
 2016
 119 S1 p. S427-S428
2 p.
 artikel
1524 PO-0738: Hydrogel injection prevents long-term rectal toxicity after radiotherapy for prostate cancer Pinkawa, M.
 2016
 119 S1 p. S345-
1 p.
 artikel
1525 PO-0781: Hypofractionated or conventional radiotherapy for early glottis cancer. Does age influence? Gutierrez Bayard, L.
 2016
 119 S1 p. S367-S368
2 p.
 artikel
1526 PO-0654: Hypofractionated StereotaticRS for patients with brain metastases. Outcome evaluation and toxicity Navarria, P.
 2016
 119 S1 p. S305-S306
2 p.
 artikel
1527 PO-0989: Hypoxic and perfusion effects of Trastuzumab in a HER2+ oesophageal adenocarcinoma xenograft model Yip, C.
 2016
 119 S1 p. S480-
1 p.
 artikel
1528 PO-0903: IGRT for a highly conformal VMAT-technique for simultaneous treatment of the breast and lymph nodes Houben-Haring, B.
 2016
 119 S1 p. S435-
1 p.
 artikel
1529 PO-0978: Image-guided impact on the brachytherapy prostate treatment quality Cerboneschi, V.
 2016
 119 S1 p. S475-S476
2 p.
 artikel
1530 PO-0742: Image-guided IMRT reduces late toxicity compared to 3D-CRT for prostate cancer Wortel, R.
 2016
 119 S1 p. S346-S347
2 p.
 artikel
1531 PO-0853: Impact of CT modality used for treatment planning of lung SBRT Vicedo-Gonzalez, A.
 2016
 119 S1 p. S406-S407
2 p.
 artikel
1532 PO-0815: Impact of digitizer response and time averaging de-noising in radiochromic film dosimetry Vera Sánchez, J.A.
 2016
 119 S1 p. S385-
1 p.
 artikel
1533 PO-0838: Impact of dosimetric outliers on the performance of a knowledge-based planning system Delaney, A.
 2016
 119 S1 p. S397-S398
2 p.
 artikel
1534 PO-0928: Impact of fuzzy-thresholding of 18F-FDG PET images for cervical cancer recurrence prediction Roman Jimenez, G.
 2016
 119 S1 p. S449-S450
2 p.
 artikel
1535 PO-0659: Impact of 68Ga-Dotatoc-PET on tumor delineation and outcome in patients with meningioma Fischer, H.
 2016
 119 S1 p. S308-
1 p.
 artikel
1536 PO-0676: Impact of IMN irradiation on the right coronary artery and OAR in right-sided post-mastectomy patients Rock, K.
 2016
 119 S1 p. S315-
1 p.
 artikel
1537 PO-0990: Impact of Ramipril on rat spinal cord after high- and low-LET irradiation Saager, M.
 2016
 119 S1 p. S480-S481
2 p.
 artikel
1538 PO-0721: Impact of sentinel lymph-node biopsy on staging and treatment in patients with anal cancer Slim, N.
 2016
 119 S1 p. S337-S338
2 p.
 artikel
1539 PO-1021: Implementation and clinical use of a digital log regarding the Traffic Light Protocol in daily IGRT Verhage, R.
 2016
 119 S1 p. S494-S495
2 p.
 artikel
1540 PO-0783: Implementation of a trial outpatient clinic to improve participation and data collection in trials Paulissen, J.
 2016
 119 S1 p. S368-S369
2 p.
 artikel
1541 PO-0810: Implementation of Normalised Dose Difference method for evaluation of VMAT Monte Carlo QA Cronholm, R.O.
 2016
 119 S1 p. S383-
1 p.
 artikel
1542 PO-0847: Implementing the new ESTRO guideline for elective breast radiotherapy with the humeral head as PRV Surmann, K.
 2016
 119 S1 p. S403-
1 p.
 artikel
1543 PO-0785: Improvement strategies and performance enhancement in Healthcare: the reorganisation of Radiotherapy Altini, M.
 2016
 119 S1 p. S369-S370
2 p.
 artikel
1544 PO-0902: Improving frameless intracranial stereotactic setup with 6DOF couch using two pre-treatment CBCTs Gagne, I.
 2016
 119 S1 p. S434-S435
2 p.
 artikel
1545 PO-0739: IMRT versus 3D conformal radiotherapy when used in combination with I-125 prostate brachytherapy Yorozu, A.
 2016
 119 S1 p. S345-S346
2 p.
 artikel
1546 PO-1018: Increase efficiency and quality? Yes please! Use project management, participation and ownership Tødenes, P.E.
 2016
 119 S1 p. S493-
1 p.
 artikel
1547 PO-0980: Inhibition of STAT3 enhances the radiosensitising effect of Temozolomide in Glioblastoma model Kim, I.A.
 2016
 119 S1 p. S476-S477
2 p.
 artikel
1548 PO-1008: In silico implementation of MRI-60Co RT. A dosimetrical comparison in cervical cancer (SIMBAD-02) Dinapoli, N.
 2016
 119 S1 p. S488-S489
2 p.
 artikel
1549 PO-0698: Integration of radiotherapy to chemotherapy for abdominal lymph node recurrence in gastric cancer Lee, J.
 2016
 119 S1 p. S326-
1 p.
 artikel
1550 PO-0997: Interferon response genes in breast cancer resistance to endocrine treatment and radiotherapy Post, A.E.M.
 2016
 119 S1 p. S484-
1 p.
 artikel
1551 PO-0908: Inter-fraction OAR dose variation in pancreatic SBRT using contrast-enhanced in-room diagnostic CT Papalazarou, C.
 2016
 119 S1 p. S437-S438
2 p.
 artikel
1552 PO-0898: Inter-fraction position of the tongue in postoperative radiotherapy of tongue cancer Dale, E.
 2016
 119 S1 p. S432-S433
2 p.
 artikel
1553 PO-0709: Interobserver variation of CT and FDG-PET based GTV for oesophageal cancer: a Dutch nationwide study Nowee, M.E.
 2016
 119 S1 p. S330-S331
2 p.
 artikel
1554 PO-0850: Interplay effect quantification of PBS lung tumour proton therapy with various fractionation schemes Zhang, Y.
 2016
 119 S1 p. S405-
1 p.
 artikel
1555 PO-0755: Intestinal toxicity from WPRT delivered with IMRT is negligible. A multicentric observational trial Sini, C.
 2016
 119 S1 p. S353-
1 p.
 artikel
1556 PO-0889: Intra-fraction re-setup with Triggered Imaging allows for margin reduction in prostate treatments Van der Weide, L.
 2016
 119 S1 p. S427-
1 p.
 artikel
1557 PO-0953: Intraoperative multicatheter implant for APBI or boost in conservative surgery of breast cancer Cambeiro, M.
 2016
 119 S1 p. S463-S464
2 p.
 artikel
1558 PO-0895: Intraprostatic calcifications as IGRT fiducial markers: analysis of 646 CBCT images in 35 patients Antognoni, P.
 2016
 119 S1 p. S431-
1 p.
 artikel
1559 PO-0901: Investigation of a fast CBCT protocol for supine accelerated whole breast Irradiation Bogaert, E.
 2016
 119 S1 p. S434-
1 p.
 artikel
1560 PO-0766: Is dose de-escalation possible in sarcoma patients treated with extended limb sparing resection? Levy, A.
 2016
 119 S1 p. S359-
1 p.
 artikel
1561 PO-0965: 125I seeds implantation under ultrasound guidance for local recurrent tumor of head and neck Jiang, P.
 2016
 119 S1 p. S469-
1 p.
 artikel
1562 PO-0685: Is PET imaging a reliable target for dose painting by numbers in lung cancer? Di Perri, D.
 2016
 119 S1 p. S320-S321
2 p.
 artikel
1563 PO-0860: Is there a “best technique” available for reducing acute toxicities in craniospinal Irradiation? Devecka, M.
 2016
 119 S1 p. S410-S411
2 p.
 artikel
1564 PO-0734: Justgin in the prevention of radio-induced vaginal mucositis Piccolo, F.
 2016
 119 S1 p. S343-
1 p.
 artikel
1565 PO-0801: Large area 2D polycrystalline CVD diamond dosimeter under intensity modulated beams Talamonti, C.
 2016
 119 S1 p. S378-
1 p.
 artikel
1566 PO-0710: Large interobserver variation of delineated target volumes of pancreatic cancer in the Netherlands Versteiine, E.
 2016
 119 S1 p. S331-S332
2 p.
 artikel
1567 PO-0887: Latency characterisation of gated radiotherapy treatment beams using a PIN Diode circuit Lempart, M.
 2016
 119 S1 p. S426-
1 p.
 artikel
1568 PO-0778: Limited short-term effect of radiotherapy on bone density in metastatic femoral bone Eggermont, F.
 2016
 119 S1 p. S365-S366
2 p.
 artikel
1569 PO-0658: Linear accelerator radiosurgery for arteriovenous malformations: a single institution experience Yahya, S.
 2016
 119 S1 p. S307-S308
2 p.
 artikel
1570 PO-0695: Lobectomy vs Stereotactic Ablative Radiotherapy in NSCLC:a multicentric series in four centers Scotti, V.
 2016
 119 S1 p. S325-
1 p.
 artikel
1571 PO-0863: Localizing the benefit of a hydrogel rectum spacer for prostate IMRT within the ano-rectal wall Vanneste, B.G.L.
 2016
 119 S1 p. S412-
1 p.
 artikel
1572 PO-0958: Locally advanced cervical cancer treated with IGABT: impact of the D90 HR-CTV on patterns of relapse Chargari, C.
 2016
 119 S1 p. S466-
1 p.
 artikel
1573 PO-0686: Locoregional failure in locally advanced non-small cell lung cancer after definitive radiotherapy Jouglar, E.
 2016
 119 S1 p. S321-
1 p.
 artikel
1574 PO-1014: Long time follow-up experience after IMRT for anal cancer: clinical outcomes and late toxicities De Meric de Bellefon, M.
 2016
 119 S1 p. S491-S492
2 p.
 artikel
1575 PO-0836: Low dose out-of-field radiation: calculation, measurement and radiobiological impact on cells Kruszyna, M.
 2016
 119 S1 p. S395-S396
2 p.
 artikel
1576 PO-0979: LTB control and toxicity for Favorable and Intmed Risk pts using real time IO-PSI prostate BT alone Raben, A.
 2016
 119 S1 p. S476-
1 p.
 artikel
1577 PO-0694: Lung toxicity modelling in thoracic post-operative RT for NSCLC and pleural mesothelioma Botticella, A.
 2016
 119 S1 p. S324-S325
2 p.
 artikel
1578 PO-0687: Machine learning method for biomarkers identification in lung cancer patients Delgado-León, B.D.
 2016
 119 S1 p. S321-
1 p.
 artikel
1579 PO-0960: Making MR-guided cervix cancer brachytherapy efficient: Are plan adaptation & daily planning needed? Skliarenko, J.
 2016
 119 S1 p. S467-
1 p.
 artikel
1580 PO-0765: Management of primary cardiac and great vessel sarcomas, The RMH experience 2000-2015 Rieu, R.
 2016
 119 S1 p. S358-S359
2 p.
 artikel
1581 PO-0833: Measured neutron spectra & dose: craniospinal irradiation on single-room passively scattered proton Howell, R.
 2016
 119 S1 p. S394-S395
2 p.
 artikel
1582 PO-0909: Merging proton radiographies with treatment planning CT for adaptive radiation therapy Gianoli, C.
 2016
 119 S1 p. S438-
1 p.
 artikel
1583 PO-0987: MiR-432 inhibits tumor progression by targeting IGSF3 in esophageal squamous cell carcinoma Liu, J.
 2016
 119 S1 p. S479-
1 p.
 artikel
1584 PO-0986: MiR-143 inhibits tumour progression by targeting STAT3 in esophageal squamous cell carcinoma Li, B.
 2016
 119 S1 p. S479-
1 p.
 artikel
1585 PO-0945: Modeling and simulation of simultaneous using of two superficial hyperthermia antennas Di Dia, A.
 2016
 119 S1 p. S459-
1 p.
 artikel
1586 PO-0873: Modelling severe late rectal bleeding in a large pooled population of prostate cancer patients Cicchetti, A.
 2016
 119 S1 p. S418-
1 p.
 artikel
1587 PO-0802: Monte-Carlo based validation of accelerator beam base data measurements Alber, M.
 2016
 119 S1 p. S378-S379
2 p.
 artikel
1588 PO-0791: Motion management and Vero dynamic tracking for SBRT in oligometastatic disease: a prospective trial Van den Begin, R.
 2016
 119 S1 p. S372-
1 p.
 artikel
1589 PO-0916: MR-based treatment planning for intracranial glioma patients Palacios, M.A.
 2016
 119 S1 p. S443-
1 p.
 artikel
1590 PO-0912: MRI-only based RT: adopting HU conversion technique for pseudo-CT construction in various body parts Korhonen, J.
 2016
 119 S1 p. S440-
1 p.
 artikel
1591 PO-0779: Multicenter study of palliative pelvic radiation for symptomatic primary and recurrent rectal cancer Cameron, M.
 2016
 119 S1 p. S366-S367
2 p.
 artikel
1592 PO-0818: Multicentre small field measurements using a new plastic scintillator detector Pasquino, M.
 2016
 119 S1 p. S386-S387
2 p.
 artikel
1593 PO-0683: Multiple training interventions improve PET/CT based target volume delineation in NSCLC RTP Konert, T.
 2016
 119 S1 p. S319-
1 p.
 artikel
1594 PO-0875: Multivariable models for urinary symptoms at 6-24 months after radical RT of prostate cancer Palorini, F.
 2016
 119 S1 p. S419-
1 p.
 artikel
1595 PO-0983: Nanoparticle mediated tumor vascular disruption: A novel strategy in radiation therapy Kunjachan, S.
 2016
 119 S1 p. S477-S478
2 p.
 artikel
1596 PO-0697: Neoadjuvant vs. adjuvant treatment of gastroesophageal junction cancer: a retrospective analysis Stessin, A.
 2016
 119 S1 p. S326-
1 p.
 artikel
1597 PO-0740: Nodal clearance rate and efficacy of individualised SN-based pelvic IMRT for prostate cancer Müller, A.
 2016
 119 S1 p. S346-
1 p.
 artikel
1598 PO-0842: Non-coplanar volumetric-modulated arc therapy for craniopharyngiomas reduces doses to hippocampus Uto, M.
 2016
 119 S1 p. S400-
1 p.
 artikel
1599 PO-0906: NTCP differences between planned and delivered dose in treatment for head and neck cancer Heukelom, J.
 2016
 119 S1 p. S436-S437
2 p.
 artikel
1600 PO-1020: Occurrence of visual phosphenes during radiation therapy of the head Timmers, A.
 2016
 119 S1 p. S494-
1 p.
 artikel
1601 PO-0931: Onset and recovery of neuronal injury following proton radiotherapy Teng, C.L.
 2016
 119 S1 p. S451-
1 p.
 artikel
1602 PO-0970: On the water equivalence of thirteen commercially available phantom materials in 192Ir brachytherapy Schoenfeld, A.
 2016
 119 S1 p. S471-S472
2 p.
 artikel
1603 PO-0911: Optimal adaptive radiotherapy strategy in head and neck to spare the parotid glands Castelli, J.
 2016
 119 S1 p. S439-S440
2 p.
 artikel
1604 PO-0919: Optimal respiratory gated FDG-PET for characterizing intra-tumour heterogeneity in lung cancer Bussink, J.
 2016
 119 S1 p. S445-
1 p.
 artikel
1605 PO-0806: Optimisation and assessment of the MLC model in the Raystation treatment planning system Savini, A.
 2016
 119 S1 p. S380-S381
2 p.
 artikel
1606 PO-1004: Optimising breast dosimetry: improving homogeneity through the application of angled IMRT fields Squires, M.
 2016
 119 S1 p. S487-
1 p.
 artikel
1607 PO-1007: Optimizing the overlap sector for patients undergoing cranio-spinal irradiation by VMAT Willemsen - Bosman, M.
 2016
 119 S1 p. S488-
1 p.
 artikel
1608 PO-0995: Osteopontin expression in glioblastoma – a promoter of the cancer stem cell-like phenotype? Rogers, S.
 2016
 119 S1 p. S483-
1 p.
 artikel
1609 PO-0668: Outcome of low and intermediate dose radiotherapy in head and neck MALT lymphoma Rahman, F.
 2016
 119 S1 p. S311-S312
2 p.
 artikel
1610 PO-0752: Outcome of prostate cancer patients treated with 3DCRT: impact of rectal/bladder preparation Maggio, A.
 2016
 119 S1 p. S351-S352
2 p.
 artikel
1611 PO-0664: Outcome of radiotherapy for stage I and II follicular lymphoma in patients staged by 18 FDG PET-CT Brady, J.L.
 2016
 119 S1 p. S309-S310
2 p.
 artikel
1612 PO-0689: Outcome predictors for moderate hypofractionated tomotherapy in Malignant Pleural Mesothelioma Fodor, A.
 2016
 119 S1 p. S322-
1 p.
 artikel
1613 PO-0630: Outcomes of induction chemotherapy for head and neck cancer patients Wu, S.Y.
 2016
 119 S1 p. S295-
1 p.
 artikel
1614 PO-0991: p53 and in vitro radiation response of fibroblasts from RT-sensitive and -resistant patients Herskind, C.
 2016
 119 S1 p. S481-
1 p.
 artikel
1615 PO-1010: Partial delegation in 2-D match set-up evaluation for H&N IGRT treatment: preliminary results Alitto, A.R.
 2016
 119 S1 p. S489-S490
2 p.
 artikel
1616 PO-0881: Patient selection for DIBH technique for left sided breast cancers: Impact of chest wall shape Chilukuri, S.
 2016
 119 S1 p. S422-
1 p.
 artikel
1617 PO-0811: Patients in vivo skin dosimetry using the Exradin W1 plastic scintillator for proton therapy Alsanea, F.
 2016
 119 S1 p. S383-S384
2 p.
 artikel
1618 PO-0690: Patient weight loss predicts worse overall survival for stage I lung cancer treated with SABR Cook, G.
 2016
 119 S1 p. S323-
1 p.
 artikel
1619 PO-0651: Pattern of failure in glioblastoma patients after FET-PET and MRI-guided chemo-radiotherapy Lundemann Jensen, M.
 2016
 119 S1 p. S304-
1 p.
 artikel
1620 PO-0688: Patterns of LR for stage III N2 NSCLC patients after chemotherapy and surgery: implications for PORT Billiet, C.
 2016
 119 S1 p. S321-S322
2 p.
 artikel
1621 PO-0704: Patterns of replase in stage III thoracic esophageal squamous cell carcinoma patients after surgery Wang, Y.X.
 2016
 119 S1 p. S328-S329
2 p.
 artikel
1622 PO-0955: PBI with interstitial HDR brachytherapy: acute and late toxicities & cosmetic results Cerboneschi, V.
 2016
 119 S1 p. S464-S465
2 p.
 artikel
1623 PO-0725: Pelvic organ motion during radiotherapy for cervical cancer and impact on target coverage Eminowicz, G.
 2016
 119 S1 p. S339-S340
2 p.
 artikel
1624 PO-0764: Perioperative brachiterapy boost in high grade soft tissue sarcomas Cortesi, A.
 2016
 119 S1 p. S358-
1 p.
 artikel
1625 PO-0703: Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal adenocarcinoma Goense, L.
 2016
 119 S1 p. S328-
1 p.
 artikel
1626 PO-0930: PET based response assessment of lung toxicity - assessment of two approaches for dose response Abravan, A.
 2016
 119 S1 p. S450-S451
2 p.
 artikel
1627 PO-0648: Pilot study in the assessment of contouring variability in stereotactic radiosurgery Sandstrom, H.
 2016
 119 S1 p. S303-
1 p.
 artikel
1628 PO-0910: Potential increase in dose delivered on a fraction by fraction basis by adapting to daily OAR DVCs Foley, D.
 2016
 119 S1 p. S438-S439
2 p.
 artikel
1629 PO-0788: Predicted patient demand for MRI Linac Sanderson, B.
 2016
 119 S1 p. S370-S371
2 p.
 artikel
1630 PO-0751: Predicting recurrence after 3DC Radiotherapy for prostate cancer: proposal for a new classifier Gabriele, P.
 2016
 119 S1 p. S351-
1 p.
 artikel
1631 PO-0732: Predictive factors for inter-fraction uterine motion in definitive radiotherapy for cervical cancer Maemoto, H.
 2016
 119 S1 p. S342-
1 p.
 artikel
1632 PO-0680: Predictive models of the extent and CT appearance of radiation induced lung injury for NSCLC Bernchou, U.
 2016
 119 S1 p. S317-S318
2 p.
 artikel
1633 PO-0737: Predictors of PSA relapse in patients with intermediate risk prostate cancer treated with SBRT Kole, T.
 2016
 119 S1 p. S344-S345
2 p.
 artikel
1634 PO-0932: Preliminary clinical study to evaluate an interactive system to segment OARs in thoracic oncology Dolz, J.
 2016
 119 S1 p. S451-S452
2 p.
 artikel
1635 PO-0832: Preliminary scanning water phantom data for beam characterisation of a hybrid MRI-Linac Woodings, S.
 2016
 119 S1 p. S394-
1 p.
 artikel
1636 PO-0716: Preoperative chemoradiation with VMAT-SIB in rectal cancer: a phase II study (Grace-Rectum-1) Picardi, V.
 2016
 119 S1 p. S335-
1 p.
 artikel
1637 PO-0905: Preparation for the first in man on the MR-Linac: virtual couch shift and on line plan adaptation Kiekebosch, I.H.
 2016
 119 S1 p. S436-
1 p.
 artikel
1638 PO-0693: Primary tumor response of locally advanced NSCLC in PET/CTs during radiochemotherapy Schimek-Jasch, T.
 2016
 119 S1 p. S324-
1 p.
 artikel
1639 PO-0827: Principal component analysis for deviation detection in 3D in vivo EPID dosimetry Rozendaal, R.A.
 2016
 119 S1 p. S391-
1 p.
 artikel
1640 PO-0971: Production of Gd-153 as a source isotope for use in rotating shield high dose rate brachytherapy Famulari, G.
 2016
 119 S1 p. S472-
1 p.
 artikel
1641 PO-0682: Prognostic factors and patterns of failure after post-op radiotherapy for epithelial thymic tumors Belkhir, F.
 2016
 119 S1 p. S318-S319
2 p.
 artikel
1642 PO-0640: Prognostic factors in definitive salvage RT for recurrent Head and Neck cancer Suzuki, O.
 2016
 119 S1 p. S300-
1 p.
 artikel
1643 PO-0696: Prognostic impact of celiac/supraclavicular node metastasis in locally advanced oesophageal cancer Cho, W.K.
 2016
 119 S1 p. S325-S326
2 p.
 artikel
1644 PO-0727: Prognostic impact of 18F-FDG PET-CT in patients with locally advanced cervical carcinoma Cima, S.
 2016
 119 S1 p. S340-S341
2 p.
 artikel
1645 PO-0735: Prognostic value of microRNA-205 in endometrial cancer patients treated with adjuvant radiotherapy Wilczynski, M.
 2016
 119 S1 p. S343-
1 p.
 artikel
1646 PO-0650: Prognostic value of minimal time to peak in dynamic 18F-FET-PET for high-grade glioma re-irradiation Fleischmann, D.F.
 2016
 119 S1 p. S304-
1 p.
 artikel
1647 PO-0714: Proposal for the delineation of the clinical target volume in biliary tract cancer radiotherapy Socha, J.
 2016
 119 S1 p. S334-S335
2 p.
 artikel
1648 PO-0753: Prospective evaluation of urinary function in patients with prostate cancer treated with RT Badenchini, F.
 2016
 119 S1 p. S351-S352
2 p.
 artikel
1649 PO-0805: Proton radiography for the clinical commissioning of the new Gantry2 head support at PSI Placidi, L.
 2016
 119 S1 p. S380-
1 p.
 artikel
1650 PO-0950: QA and dummy-run results of the TRENDY randomized trial on SBRT vs. chemoembolization for HCC Habraken, S.J.M.
 2016
 119 S1 p. S462-
1 p.
 artikel
1651 PO-0730: QOL after postoperative IMRT for cervical cancer: results from matched pair analysis with 3DCRT Chopra, S.
 2016
 119 S1 p. S341-S342
2 p.
 artikel
1652 PO-1023: Quality assurance for IMRiS phase II study of IMRT in sarcomas: a survey of limb immobilisation Simões, R.
 2016
 119 S1 p. S495-S496
2 p.
 artikel
1653 PO-0731: Quality of life of women after endometrial cancer: the role of the vaginal dilator Foerster, R.
 2016
 119 S1 p. S342-
1 p.
 artikel
1654 PO-0883: Quantification of Duodenum motion: analysis from respiratory phase guided radiotherapy planning scan Basu, T.
 2016
 119 S1 p. S423-S424
2 p.
 artikel
1655 PO-0859: Quantifying and categorizing plan rejections as a part of the clinical process improvement Speirs, C.
 2016
 119 S1 p. S410-
1 p.
 artikel
1656 PO-0951: Radiation beam alignment and baseline dosimetry measurements for the Australian MRI-linac program Begg, J.
 2016
 119 S1 p. S462-S463
2 p.
 artikel
1657 PO-0871: Radiation-induced lung damage: beyond dose-volume histogram analysis Monti, S.
 2016
 119 S1 p. S416-S417
2 p.
 artikel
1658 PO-0790: Radiation-induced mesothelioma among solid cancer survivors: an analysis of the seer cohort Farioli, A.
 2016
 119 S1 p. S372-
1 p.
 artikel
1659 PO-0761: Radiation therapy for angiosarcoma of the scalp: total scalp irradiation with X-rays and electrons Hata, M.
 2016
 119 S1 p. S356-S357
2 p.
 artikel
1660 PO-0675: Radical radiotherapy in ologometastatic breast cancer patients Trovo, M.
 2016
 119 S1 p. S315-
1 p.
 artikel
1661 PO-0641: Radiosurgery for intracranial meningioma. A systematic review and meta-analysis Pinzi, V.
 2016
 119 S1 p. S300-S301
2 p.
 artikel
1662 PO-0656: Radiosurgery in brain metastases: a mono-institutional experience Pelle, E.
 2016
 119 S1 p. S306-
1 p.
 artikel
1663 PO-0642: Radiosurgery without whole brain radiotherapy in brain metastases from non-small cell lung cancer Anselmo, P.
 2016
 119 S1 p. S301-
1 p.
 artikel
1664 PO-0776: Radiotherapy for painful bone metastases: clinical predictors of efficacy Bychkova, N.
 2016
 119 S1 p. S364-
1 p.
 artikel
1665 PO-1011: Radiotherapy of brain metastases. Relationship with patients age an Karnofsky Index Monroy Anton, J.L.
 2016
 119 S1 p. S490-
1 p.
 artikel
1666 PO-1016: Radiotherapy students’ perceptions of skills training simulation using a bariatric suit Khine, R.N.M.
 2016
 119 S1 p. S492-
1 p.
 artikel
1667 PO-0681: Randomized phase II study of Erlotinib with radiotherapy in irresectable non small cell lung cancer Martinez, E.
 2016
 119 S1 p. S318-
1 p.
 artikel
1668 PO-0637: RCT pilot study of Therabite vs wooden spatula in amelioration of trismus in H&N cancer patients Lee, R.
 2016
 119 S1 p. S298-
1 p.
 artikel
1669 PO-0879: Real-time prostate tracking in prostate cancer radiotherapy using autoscan transperineal ultrasound Qi, X.
 2016
 119 S1 p. S421-S422
2 p.
 artikel
1670 PO-0999: Reduced side effects by proton minibeam radiotherapy in a mouse ear model Schmid, T.E.
 2016
 119 S1 p. S485-
1 p.
 artikel
1671 PO-1019: Reflective practice: What is its impact on therapy radiographers practice? Rodgers, J.
 2016
 119 S1 p. S493-S494
2 p.
 artikel
1672 PO-0773: Reirradiation by extracranial stereotactic treatment: preliminary results of a dose escalation study Deodato, F.
 2016
 119 S1 p. S363-
1 p.
 artikel
1673 PO-0711: Relating CT image heterogeneity to patient outcome in the SCOPE 1 oesophageal cancer trial Carrington, R.
 2016
 119 S1 p. S332-S333
2 p.
 artikel
1674 PO-1025: Reproducibility of prone immobilization in breast treatment – a retrospective study Rodrigues, N.
 2016
 119 S1 p. S496-S497
2 p.
 artikel
1675 PO-1024: Residual interfraction error after orthogonal kV in stereotactic RT. Analyses from 139 CBCT scans Manfrida, S.
 2016
 119 S1 p. S496-
1 p.
 artikel
1676 PO-0884: Respiratory motion models from Cone-Beam CT for lung tumour tracking Fassi, A.
 2016
 119 S1 p. S424-
1 p.
 artikel
1677 PO-0759: Results of radical radiotherapy with a tumour boost for bladder cancer in patients unfit for surgery Lutkenhaus, L.J.
 2016
 119 S1 p. S355-S356
2 p.
 artikel
1678 PO-0961: Retrospective dosimetric comparison of TG43 and a commercially MBDCA for gynecological brachytherapy Pinto, S.
 2016
 119 S1 p. S467-S468
2 p.
 artikel
1679 PO-0747: Revisiting guidelines for target definition after prostatectomy when taking MRI study into account Pardo, G. Sancho
 2016
 119 S1 p. S349-
1 p.
 artikel
1680 PO-0671: Risk of cardiac damage after mediastinal radiotherapy for Hodgkin’s disease Buglione, M.
 2016
 119 S1 p. S313-S314
2 p.
 artikel
1681 PO-0669: Risk of second malignant neoplasms among long-term survivors of extranodal NK/T-cell lymphoma Chen, B.
 2016
 119 S1 p. S312-
1 p.
 artikel
1682 PO-0775: Risk stratification of vertebral compression fracture after palliative RT for spinal metastases Yu, T.
 2016
 119 S1 p. S364-
1 p.
 artikel
1683 PO-1022: Robotic radiosurgery for vestibular schwannomas - the early tumor response and treatment tolerance Wzietek, I.
 2016
 119 S1 p. S495-
1 p.
 artikel
1684 PO-0899: Robustness of fractionated photon RT for pancreatic cancer: Dosimetric effects of anatomical changes Van der Horst, A.
 2016
 119 S1 p. S433-
1 p.
 artikel
1685 PO-0763: Ruthenium-106 brachytherapy for choroidal melanoma: high efficacy with improved visual outcome Peters, F.P.
 2016
 119 S1 p. S357-S358
2 p.
 artikel
1686 PO-0691: SABR for central lung tumors: plan quality and long-term clinical outcomes Tekatli, H.
 2016
 119 S1 p. S323-
1 p.
 artikel
1687 PO-0636: Safety profile support efficacy of gingival clonidine tablet to prevent severe oral mucositis in HNC Tao, Y.
 2016
 119 S1 p. S297-S298
2 p.
 artikel
1688 PO-0700: Salvage radiotherapy in the patients with supraclavicular lymph node metastases after esophagectomy Zhou, Z.G.
 2016
 119 S1 p. S327-
1 p.
 artikel
1689 PO-0757: SBRT for prostate cancer using tomotherapy: interim analysis of a prospective trial in 82 patients Macias Hernandez, V.
 2016
 119 S1 p. S354-
1 p.
 artikel
1690 PO-0667: Second malignancies after TBI in AHCT for relapsed follicular lymphoma Tisseverasinghe, S.
 2016
 119 S1 p. S311-
1 p.
 artikel
1691 PO-0816: Sensitivity and reproducibility of the portal imaging panel for routine FFF QC measurements Willett, A.
 2016
 119 S1 p. S385-S386
2 p.
 artikel
1692 PO-0717: Serum miR-345-5p predicts pathological response to chemoradiotherapy in local advanced rectal cancer Yu, J.
 2016
 119 S1 p. S336-
1 p.
 artikel
1693 PO-1026: Setup accuracy of DIBH for breast treatment with a simultaneous integrated boost Kraan, B.
 2016
 119 S1 p. S497-
1 p.
 artikel
1694 PO-0652: SFRT of the resection cavity in patients with one to three brain metastases Bilger, A.
 2016
 119 S1 p. S305-
1 p.
 artikel
1695 PO-0723: Short time interval between radiation and hyperthermia improves treatment outcome in cervical cancer Van Leeuwen, C.M.
 2016
 119 S1 p. S338-S339
2 p.
 artikel
1696 PO-0745: Significant correlation between prostate volume and obstructive voiding symptom in hypofractionation Echagüen, S. Pérez
 2016
 119 S1 p. S348-
1 p.
 artikel
1697 PO-0925: Simulation of FMISO diffusion-retention in a three-dimensional tumor model Wack, L.J.
 2016
 119 S1 p. S448-
1 p.
 artikel
1698 PO-0848: Simultaneous integrated protection (SIP): a new concept for high precision radiation therapy Brunner, T.
 2016
 119 S1 p. S403-S404
2 p.
 artikel
1699 PO-0937: Sound speed reconstruction in full wave ultrasound computer tomography for breast cancer detection Perez-Liva, M.
 2016
 119 S1 p. S454-S455
2 p.
 artikel
1700 PO-0746: Spanish validation of Charlson Index applied to prostate cancer Casas i Duran, F.
 2016
 119 S1 p. S348-S349
2 p.
 artikel
1701 PO-0944: Stability in leaf position of 3 generations of optical digitally controlled Multi Leaf Collimators Bertelsen, A.
 2016
 119 S1 p. S458-S459
2 p.
 artikel
1702 PO-0722: Stereotactic ablative radiatiotherapy for lung oligometastatic patients with colorectal cancer Agolli, L.
 2016
 119 S1 p. S338-
1 p.
 artikel
1703 PO-0728: Stereotactic Body Radiation Therapy for oligometastatic patients with ovarian cancer Tozzi, A.
 2016
 119 S1 p. S341-
1 p.
 artikel
1704 PO-0782: Stereotactic body radiation therapy for primary lung cancer in the elderly Larrea, L.
 2016
 119 S1 p. S368-
1 p.
 artikel
1705 PO-0726: Stereotactic body radiotherapy for mediastinal and subdiaphragmatic nodal relapse of ovarian cancer Draghini, L.
 2016
 119 S1 p. S340-
1 p.
 artikel
1706 PO-0743: Stereotactic body radiotherapy in recurrent lymph nodes metastases from prostate cancer Trippa, F.
 2016
 119 S1 p. S347-
1 p.
 artikel
1707 PO-0712: Stereotactic body radiotherapy in the treatment of inoperable hepatocellular carcinoma Franco, P.
 2016
 119 S1 p. S333-
1 p.
 artikel
1708 PO-0643: Stereotactic hypofractionation in combination with radiosurgery in the treatment of brain metastases Ivanov, P.
 2016
 119 S1 p. S301-
1 p.
 artikel
1709 PO-0770: Subsequent colorectal adenomas in childhood cancer survivors: a DCOG LATER record linkage study Teepen, J.
 2016
 119 S1 p. S360-S361
2 p.
 artikel
1710 PO-0647: Subventricular zones: new key targets for glioblastoma treatment Khalifa, J.
 2016
 119 S1 p. S302-S303
2 p.
 artikel
1711 PO-0706: Supraclavicular lymphnode disease is not an independent prognostic factor in esophageal cancer Jeene, P.
 2016
 119 S1 p. S329-S330
2 p.
 artikel
1712 PO-0653: Surgical interventions after previous SBRT of the spine - increased risk for complications? Roesch, J.
 2016
 119 S1 p. S305-
1 p.
 artikel
1713 PO-1017: Survey of image-guided radiation therapy use in Australia Batumalai, V.
 2016
 119 S1 p. S492-S493
2 p.
 artikel
1714 PO-0769: Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation Janssens, G.O.R.J.
 2016
 119 S1 p. S360-
1 p.
 artikel
1715 PO-0719: Target delineation of anal cancer based on MR or PET - an inter-observer, inter-modality study Rusten, E.
 2016
 119 S1 p. S336-S337
2 p.
 artikel
1716 PO-0655: Targeted therapy and stereotactic radiotherapy in brain metastases from renal cell carcinoma Anselmo, P.
 2016
 119 S1 p. S306-
1 p.
 artikel
1717 PO-0784: Targeting general practitioners: prospective outcomes of a nationwide GP education programme Morris, L.
 2016
 119 S1 p. S369-
1 p.
 artikel
1718 PO-0646: Temozolomide during radiotherapy of glioblastoma multiforme: daily administration improves survival Nachbichler, S.
 2016
 119 S1 p. S302-
1 p.
 artikel
1719 PO-0771: Temporal changes in pediatric radiation oncology: DCOG LATER childhood cancer survivor study Kok, J.
 2016
 119 S1 p. S361-S362
2 p.
 artikel
1720 PO-0977: Ten year patient reported Quality of Life following I-125 prostate brachytherapy monotherapy Henry, A.
 2016
 119 S1 p. S475-
1 p.
 artikel
1721 PO-0672: Ten years experience of breast reconstruction after mastectomy in previously irradiated patients Di Donato, A.
 2016
 119 S1 p. S314-
1 p.
 artikel
1722 PO-0793: The Advanced Markus ionization chamber is useable for measurements at ultra high dose rates Petersson, K.
 2016
 119 S1 p. S373-
1 p.
 artikel
1723 PO-0852: The dose in marrow of iliac plates during radiotherapy of cervical and endometrial cancer Jodda, A.
 2016
 119 S1 p. S406-
1 p.
 artikel
1724 PO-0939: The dosimetric consequences of delineation variation for cervical external beam radiotherapy Eminowicz, G.
 2016
 119 S1 p. S455-S456
2 p.
 artikel
1725 PO-0896: The effect of bladder volume on bowel dose in the treatment of anal cancer using IMRT McDonald, K.
 2016
 119 S1 p. S431-S432
2 p.
 artikel
1726 PO-0878: The effect of rectal retractor on intra-fraction motion of prostate Vanhanen, A.
 2016
 119 S1 p. S420-S421
2 p.
 artikel
1727 PO-0846: The impact of anatomical changes on the accumulated carbon ion dose in pancreatic cancer patients Houweling, A.C.
 2016
 119 S1 p. S402-S403
2 p.
 artikel
1728 PO-0707: The impact of dose on survival in adjuvant chemoradiation pancreatic cancer De Filippo, L.
 2016
 119 S1 p. S330-
1 p.
 artikel
1729 PO-0917: The impact of irregular respiratory patterns on tumour volumes in 4DCT Huizing, E.
 2016
 119 S1 p. S443-S444
2 p.
 artikel
1730 PO-0888: The influence of breathing motion on the precision of delivered dose to breast cancer patients Agergaard, S.
 2016
 119 S1 p. S426-S427
2 p.
 artikel
1731 PO-0662: The multi-institutional retrospective study of radiation therapy for NK/T-cell lymphoma in Japan Oguchi, M.
 2016
 119 S1 p. S309-
1 p.
 artikel
1732 PO-0940: The problems found within the on-site dosimetry audits of radiotherapy centres in the Czech Republic Koniarova, I.
 2016
 119 S1 p. S456-
1 p.
 artikel
1733 PO-0631: The prognostication of tumour volume and lower neck lymph nodes in laryngeal cancer treated with IMRT Huang, S.H.
 2016
 119 S1 p. S295-
1 p.
 artikel
1734 PO-0982: Therapeutic potential of the YB-1/Notch-3 interaction in prostate cancer McDermott, N.
 2016
 119 S1 p. S477-
1 p.
 artikel
1735 PO-0998: The Robo1-receptor is involved in the migration of irradiated glioblastoma cells Bühler, H.
 2016
 119 S1 p. S484-S485
2 p.
 artikel
1736 PO-0992: The role of HIF-1 in the neo-vascularization of the rectal mucosa after radiation therapy Eusebi, L.
 2016
 119 S1 p. S481-S482
2 p.
 artikel
1737 PO-0718: The significance of postop CEA after preoperative CRT followed by TME in advanced rectal cancer Jeong, S.
 2016
 119 S1 p. S336-
1 p.
 artikel
1738 PO-0702: The use of pet texture analysis to predict lymph node metastases in patients with oesophageal cancer Foley, K.
 2016
 119 S1 p. S327-S328
2 p.
 artikel
1739 PO-0872: The variability of the RBE in proton therapy: can we base it on empirical clinical data? Lühr, A.
 2016
 119 S1 p. S417-
1 p.
 artikel
1740 PO-0933: Towards standardisation of PET auto-segmentation with the ATLAAS machine learning algorithm Berthon, B.
 2016
 119 S1 p. S452-
1 p.
 artikel
1741 PO-0824: Treatment couch modeling in Elekta Monaco treatment planning system Huertas, C.
 2016
 119 S1 p. S389-S390
2 p.
 artikel
1742 PO-0699: Treatment of metachronous esophageal cancer after head and neck cancer Fan, K.H.
 2016
 119 S1 p. S326-S327
2 p.
 artikel
1743 PO-0867: Treatment planning study for spatially fractionated minibeam radiotherapy Alexander, A.
 2016
 119 S1 p. S414-
1 p.
 artikel
1744 PO-0733: Treatment response evaluation with ADCmean in cervical cancer patient treated with chemoradiotherapy Onal, C.
 2016
 119 S1 p. S342-S343
2 p.
 artikel
1745 PO-0663: Treatment result of primary thyroid lymphoma; a single institute experience Yoshikawa, N.
 2016
 119 S1 p. S309-
1 p.
 artikel
1746 PO-0789: Treatment time in breast irradiation: a trade-off between positioning and complexity Monten, C.
 2016
 119 S1 p. S371-
1 p.
 artikel
1747 PO-0822: Tumor margin estimation by multiple Bragg peak detection in carbon ion therapy Ferraz Dias, M.F.
 2016
 119 S1 p. S388-S389
2 p.
 artikel
1748 PO-0736: Tumour staging using MRI in prostate cancer: improvement of treatment decisions for radiotherapy Couñago, F.
 2016
 119 S1 p. S344-
1 p.
 artikel
1749 PO-0974: Urethral and bladder dose of total and focal salvage brachytherapy: toxicity and dose constraints Peters, M.
 2016
 119 S1 p. S474-
1 p.
 artikel
1750 PO-0808: Validation of a clinical peripheral photon dose model: prostate IMRT irradiation of Alderson phantom Sanchez-Nieto, B.
 2016
 119 S1 p. S381-S382
2 p.
 artikel
1751 PO-0803: Validation of a pre-treatment delivery quality assurance method for the CyberKnife Synchrony System Mastella, E.
 2016
 119 S1 p. S379-
1 p.
 artikel
1752 PO-0918: Validation of freeware-based mid-ventilation CT calculation for upper abdominal cancer patients Vieira, S.
 2016
 119 S1 p. S444-S445
2 p.
 artikel
1753 PO-0798: Validation of Monte Carlo calculated correction factors for MRI-linac reference dosimetry O'Brien, D.J.
 2016
 119 S1 p. S376-
1 p.
 artikel
1754 PO-1015: Virtual training in patient information sessions prior to external beam radiotherapy Stewart-Lord, A.
 2016
 119 S1 p. S492-
1 p.
 artikel
1755 PO-0947: VMAT-based grid for spatially fractionated radiation therapy Gholami, S.
 2016
 119 S1 p. S460-
1 p.
 artikel
1756 PO-0942: VMAT planning and treatment preparation process adapted for failure mode and effect analysis Khater, N.
 2016
 119 S1 p. S457-
1 p.
 artikel
1757 PO-1009: VMAT planning approach to avoid superficial underdosage for accelerated partial breast irradiation Zucconi, F.
 2016
 119 S1 p. S489-
1 p.
 artikel
1758 PO-0820: Volumetric quality assurance of RapidArc plans for multiple intracranial targets using gel dosimetry Khater, N.
 2016
 119 S1 p. S387-S388
2 p.
 artikel
1759 PO-0926: Voxel-based PSMA-PET/histopathology analysis in patients with primary prostate cancer Zamboglou, C.
 2016
 119 S1 p. S448-S449
2 p.
 artikel
1760 PO-0840: Voxel-based ΔTCP distribution:a tool to study the impact of dose distributions in tumour outcome Fabri, D.
 2016
 119 S1 p. S399-
1 p.
 artikel
1761 PO-0876: Voxel-by-voxel NTCP model for lung density changes after IMRT Avanzo, M.
 2016
 119 S1 p. S419-S420
2 p.
 artikel
1762 PO-0754: Whole body Integral dose is associated with radiotherapy related fatigue in prostate cancer Joseph, N.
 2016
 119 S1 p. S352-S353
2 p.
 artikel
1763 PO-0861: Whole lung irradiation using VMAT – dosimetric and NTCP benefits vs. second cancer risks Clarke, P.
 2016
 119 S1 p. S411-
1 p.
 artikel
1764 PV-0512: Accelerated partial breast irradiation for Luminal-A breast cancer: analysis from a phase 3 trial Meattini, I.
 2016
 119 S1 p. S242-
1 p.
 artikel
1765 PV-0223: Accuracy of 2D angiogram to 3D MRI registration for frameless stereotactic targeting of brain AVM Kuijper, I.T.
 2016
 119 S1 p. S101-
1 p.
 artikel
1766 PV-0276: Adaptive radiotherapy: rate of "marginal" failure after "replanning" in combined treatment of NSCLC Silipigni, S.
 2016
 119 S1 p. S128-S129
2 p.
 artikel
1767 PV-0429: A 3D in vitro cancer model and imaging platform to measure proton radiation-induced cellular damage Long, T.
 2016
 119 S1 p. S200-
1 p.
 artikel
1768 PV-0280: Adjuvant radiotherapy in abdominal desmoplastic small round cell tumor: analysis of 107 patients Atallah, V.
 2016
 119 S1 p. S131-
1 p.
 artikel
1769 PV-0037: Application of brachytherapy for residual nasopharyngeal carcinoma after external beam radiotherapy Cheng, G.
 2016
 119 S1 p. S15-
1 p.
 artikel
1770 PV-0033: Assessing dose contribution to pelvic lymph nodes in intracavitary brachytherapy for cervical cancer Chua, G.W.Y.
 2016
 119 S1 p. S13-S14
2 p.
 artikel
1771 PV-0171: Can protons reduce bone marrow toxicity in definitive chemoradiotherapy for oesophageal tumours? Warren, S.
 2016
 119 S1 p. S81-
1 p.
 artikel
1772 PV-0378: CBCT derived CTV-PTV margins for elective pelvic node irradiation of prostate cancer patients Lyons, C.A.
 2016
 119 S1 p. S176-S177
2 p.
 artikel
1773 PV-0431: Changes of the density CD8+ tumour infiltrating lymphocytes after neoadjuvant radiochemotherapy Buka, D.
 2016
 119 S1 p. S201-
1 p.
 artikel
1774 PV-0125: Chemoradiation+surgery vs chemoradiation+BRT in advanced cervical carcinoma: a case-control study Cima, S.
 2016
 119 S1 p. S57-
1 p.
 artikel
1775 PV-0514: Chest wall radiotherapy and complications after flap reconstruction Rao, Y.
 2016
 119 S1 p. S243-
1 p.
 artikel
1776 PV-0122: Clinical factors as a selection tool for organ-preserving treatment strategies in rectal cancer Joye, I.
 2016
 119 S1 p. S55-S56
2 p.
 artikel
1777 PV-0086: Clinical implementation of research within a radiotherapy department. A quality indicator? Jacobs, M.
 2016
 119 S1 p. S41-S42
2 p.
 artikel
1778 PV-0375: Comparison of carina- versus bony anatomy-based registration for IGRT in esophageal cancer Machiels, M.
 2016
 119 S1 p. S175-
1 p.
 artikel
1779 PV-0474: Comparison of DCE MRI and FMISO-PET kinetic parameters in head and neck cancer patients Simoncic, U.
 2016
 119 S1 p. S225-S226
2 p.
 artikel
1780 PV-0376: Contrast-enhanced respiration managed cone-beam CT for image-guided intrahepatic radiotherapy Lock, M.
 2016
 119 S1 p. S175-S176
2 p.
 artikel
1781 PV-0089: CyberKnife for prostate cancer patients – early results of 350 patients irradiation Miszczyk, L.
 2016
 119 S1 p. S42-S43
2 p.
 artikel
1782 PV-0424: Cyclin D1 silencing radiosensitises prostate cancer cells by impairing DNA-DSBs repair pathways Marampon, F.
 2016
 119 S1 p. S198-
1 p.
 artikel
1783 PV-0379: 4D Cone-Beam CT reconstruction with 60s acquisition and 60s reconstruction Hansen, D.
 2016
 119 S1 p. S177-S178
2 p.
 artikel
1784 PV-0473: Diagnostic and predictive values of quantitative analysis on T2-w and ADC map MRI in prostate cancer Gnep, K.
 2016
 119 S1 p. S225-
1 p.
 artikel
1785 PV-0124: Does daily intake of resistant starch reduce the acute bowel symptoms in pelvic radiotherapy? RCT Sasidharan, B.K.
 2016
 119 S1 p. S56-S57
2 p.
 artikel
1786 PV-0173: Dosimetric assessment of three-source Co-60 and Linacbased lung SBRT for feasibility of MR-IGRT Dogan, N.
 2016
 119 S1 p. S82-
1 p.
 artikel
1787 PV-0563: Dosimetric comparisons of 1H, 4He, 12C and 16O ion beams at HIT Tessonnier, T.
 2016
 119 S1 p. S271-
1 p.
 artikel
1788 PV-0036: Dosimetric evaluation of 3D printed applicators for High Dose Rate brachytherapy Vavassori, A.
 2016
 119 S1 p. S14-S15
2 p.
 artikel
1789 PV-0565: Dosimetric response maps of diode and diamond detectors in kilovoltage synchrotron beams Wright, T.
 2016
 119 S1 p. S272-
1 p.
 artikel
1790 PV-0477: Early CT image biomarkers change and xerostomia score are strong predictors for late xerostomia Van Dijk, L.V.
 2016
 119 S1 p. S227-S228
2 p.
 artikel
1791 PV-0091: Early salvage RT for PSA recurrence postprostatectomy improves biochemical progression free survival Hopper, A.B.
 2016
 119 S1 p. S43-S44
2 p.
 artikel
1792 PV-0425: EEF2K promotes progression and radioresistance of esophageal squamous cell carcinoma Zhu, H.C.
 2016
 119 S1 p. S198-
1 p.
 artikel
1793 PV-0035: Electronic brachytherapy for basal cell carcinoma: two prospective pilot trials with different doses Pons, O.
 2016
 119 S1 p. S14-
1 p.
 artikel
1794 PV-0222: Enhancing safety and quality of the radiotherapy process using a multidisciplinary end-to-end review Albers, M.
 2016
 119 S1 p. S100-S101
2 p.
 artikel
1795 PV-0510: Evaluation of a breast cancer nomogram to predict local relapse after breast conserving therapy Kindts, I.
 2016
 119 S1 p. S241-
1 p.
 artikel
1796 PV-0176: Evaluation of biologically effective dose in stereotactic radiotherapy for prostate cancer Viren, T.
 2016
 119 S1 p. S84-
1 p.
 artikel
1797 PV-0564: Experimental validation of proton stopping power calculations based on dual energy CT imaging Van Abbema, J.K.
 2016
 119 S1 p. S271-S272
2 p.
 artikel
1798 PV-0174: Experimental verification of 4D Monte Carlo calculations of dose delivered to a moving anatomy Cygler, J.
 2016
 119 S1 p. S82-S83
2 p.
 artikel
1799 PV-0428: Factor 2.5 radiosensitivity difference determined by ex vivo γH2AX assay in prostate cancer patients De Colle, C.
 2016
 119 S1 p. S199-S200
2 p.
 artikel
1800 PV-0121: Falcon based Clinical Target Volume Delineation to support Inter-Society Rectal Cancer Guidelines Gambacorta, M.
 2016
 119 S1 p. S55-
1 p.
 artikel
1801 PV-0476: Fractional anisotropy dose-response relationship of the corpus callosum Pettersson, N.
 2016
 119 S1 p. S227-
1 p.
 artikel
1802 PV-0120: Gastric fundus irradiation increases risk of postoperative anastomotic leakage in esophageal cancer Goense, L.
 2016
 119 S1 p. S54-S55
2 p.
 artikel
1803 PV-0123: Gender and secondary malignancies in rectal cancer patients with and without radiation therapy Warschkow, R.
 2016
 119 S1 p. S56-
1 p.
 artikel
1804 PV-0515: GTV delineation of laryngopharyngeal carcinoma on PET is more accurate than on CT and MRI Ligtenberg, H.
 2016
 119 S1 p. S243-S244
2 p.
 artikel
1805 PV-0516: Guideline development for tumor delineation on MR-images for laryngeal and hypophargeal cancer Jager, E.
 2016
 119 S1 p. S244-
1 p.
 artikel
1806 PV-0562: Hadron-therapy monitoring with in-beam PET: measurements and simulations of the INSIDE PET scanner Pennazio, F.
 2016
 119 S1 p. S270-
1 p.
 artikel
1807 PV-0034: HDR BT alone in endometrial cancer: up-date of Piedmont experience in 18 years (71 patients) Gribaudo, S.
 2016
 119 S1 p. S14-
1 p.
 artikel
1808 PV-0511: Hypofractionated VMAT for early stage breast cancer: acute toxicity and cosmesis in 840 patients Iftode, C.
 2016
 119 S1 p. S241-S242
2 p.
 artikel
1809 PV-0281: (ICORG 05-03): Radiotherapy in malignant spinal cord compression; The quality of life analysis Lee, K.
 2016
 119 S1 p. S131-
1 p.
 artikel
1810 PV-0229: IGRT for pediatric patients: How much can we reduce the dose? Johansen, L.
 2016
 119 S1 p. S104-
1 p.
 artikel
1811 PV-0566: Improving image reconstruction for Compton camera based imaging for proton radiotherapy verification Draeger, E.
 2016
 119 S1 p. S273-
1 p.
 artikel
1812 PV-0275: IMRT for non-small cell lung cancer: a decade of experience at the Ghent University Hospital Deseyne, P.
 2016
 119 S1 p. S128-
1 p.
 artikel
1813 PV-0377: Inter-fraction bladder variations in RT of prostate cancer: impact on dose surface maps Botti, A.
 2016
 119 S1 p. S176-
1 p.
 artikel
1814 PV-0225: Investigating optimal modality for boost treatment of left breast with deep inspiration breath hold Sen, A.
 2016
 119 S1 p. S102-
1 p.
 artikel
1815 PV-0175: Knowledge-based DVH predictions for automated individualised treatment plan quality assurance Tol, J.
 2016
 119 S1 p. S83-S84
2 p.
 artikel
1816 PV-0430: Late radiation enteropathy: do tissue cytokines play a protective role? A first-in-man study Reis Ferreira, M.
 2016
 119 S1 p. S200-S201
2 p.
 artikel
1817 PV-0432: Mechanisms and abscopal effects of combined mRNA-based radioimmunotherapy in a syngenic mouse model Basler, L.
 2016
 119 S1 p. S201-S202
2 p.
 artikel
1818 PV-0329: Modulation indexes for predicting interplay effects in lung SABR treatments Puxeu Vaqué, J.
 2016
 119 S1 p. S152-
1 p.
 artikel
1819 PV-0040: MRI guided focal primary and (secondary) salvage HDR-BT in prostate cancer patients seems safe Maenhout, M.
 2016
 119 S1 p. S16-S17
2 p.
 artikel
1820 PV-0038: Multivariable model development for mortality after total salvage Iodine-125 prostate brachytherapy Peters, M.
 2016
 119 S1 p. S16-
1 p.
 artikel
1821 PV-0087: Non-publication of Phase-3 clinical trials in radiotherapy Perez-Alija, J.
 2016
 119 S1 p. S42-
1 p.
 artikel
1822 PV-0119: Pattern of regional recurrence in adenocarcinoma of GEJ: implication for target delineation Zhang, J.
 2016
 119 S1 p. S54-
1 p.
 artikel
1823 PV-0226: Pattern of relapse of glioblastoma treated with Stupp protocol:could a margin reduction be proposed? Pedretti, S.
 2016
 119 S1 p. S102-S103
2 p.
 artikel
1824 PV-0518: Phase 1 study of Debio 1143 in combination with Concurrent Chemo-Radiotherapy in LA-SCCHN Tao, Y.
 2016
 119 S1 p. S245-S246
2 p.
 artikel
1825 PV-0478: Predicting pulmonary function loss in lung cancer radiotherapy patients using CT ventilation imaging Brink, C.
 2016
 119 S1 p. S228-S229
2 p.
 artikel
1826 PV-0475: Probability map prediction of relapse areas in glioblastoma patients using multi-parametric MR Laruelo, A.
 2016
 119 S1 p. S226-S227
2 p.
 artikel
1827 PV-0118: Prognostic impact of presurgical Ca 19-9 level in pancreatic adenocarcinoma: a pooled analysis Mattiucci, G.C.
 2016
 119 S1 p. S53-S54
2 p.
 artikel
1828 PV-0323: Prospective evaluation of markerless tumour tracking using 4D3D registration and dual energy imaging Dhont, J.
 2016
 119 S1 p. S148-S149
2 p.
 artikel
1829 PV-0227: Radiotherapy in elderly patients with lung cancer. Performance status and fractionation analysis Monroy Anton, J.L.
 2016
 119 S1 p. S102-S103
2 p.
 artikel
1830 PV-0088: Rapid changes in brain metastasis during radiosurgical planning – implications for MRI timing Salkeld, A.L.
 2016
 119 S1 p. S42-
1 p.
 artikel
1831 PV-0427: Real-time tumour oxygenation changes following a single high dose radiotherapy in mouse lung cancers Song, C.
 2016
 119 S1 p. S199-
1 p.
 artikel
1832 PV-0328: Rectal immobilisation device in stereotactic prostate treatment: intrafraction motion and dosimetry De Leon, J.
 2016
 119 S1 p. S151-S152
2 p.
 artikel
1833 PV-0326: Respiratory gating guided by internal electromagnetic motion monitoring during liver SBRT Poulsen, P.
 2016
 119 S1 p. S150-S151
2 p.
 artikel
1834 PV-0325: Retrospective self-sorted 4D-MRI for the liver Van de Lindt, T.
 2016
 119 S1 p. S149-S150
2 p.
 artikel
1835 PV-0230: Risk assessment of solid secondary malignancies in childhood Hodgkin Lymphoma after radiotherapy Zanella, G.
 2016
 119 S1 p. S104-S105
2 p.
 artikel
1836 PV-0279: Role of IFRT prior or after autologous stem cell rescue for refractory or relapsed Hodgkin lymphoma Levis, M.
 2016
 119 S1 p. S130-S131
2 p.
 artikel
1837 PV-0277: SBRT with concurrent chemoradiation in stage III NSCLC: first results of the phase I Hybrid trial Peulen, H.
 2016
 119 S1 p. S129-
1 p.
 artikel
1838 PV-0172: Selecting patients with lung cancer for proton therapy should be based on multivariable NTCP models Kramer, M.C.A.
 2016
 119 S1 p. S81-S82
2 p.
 artikel
1839 PV-0228: Size and impact of intra-fractional changes in baseline shift during lung SBRT Kamphuis, M.
 2016
 119 S1 p. S103-S104
2 p.
 artikel
1840 PV-0090: Stereotactic body radiotherapy for localized prostate cancer: a 7-year experience Lin, Y.W.
 2016
 119 S1 p. S43-
1 p.
 artikel
1841 PV-0426: Targeting PI4K for radiosensitisation: a viable model of drug repositioning Kim, I.A.
 2016
 119 S1 p. S198-S199
2 p.
 artikel
1842 PV-0519: The hypoxic radiosensitizer, nimorazole, in RT of HNSCC: pharmacokinetics, toxicity and compliance Metwally, M.A.H.
 2016
 119 S1 p. S246-
1 p.
 artikel
1843 PV-0513: The impact of chemotherapy on toxicity in the era of hypofractionated radiotherapy De Santis, M.C.
 2016
 119 S1 p. S242-S243
2 p.
 artikel
1844 PV-0085: The level of innovations routinely implemented in Dutch radiotherapy centers:a cross-sectional study Jacobs, M.
 2016
 119 S1 p. S40-S41
2 p.
 artikel
1845 PV-0224: To be greeted as a human being - A meta-synthesis of cancer patients' experiences of radiotherapy Petri, S.
 2016
 119 S1 p. S101-S102
2 p.
 artikel
1846 PV-0517: Upfront vs. no upfront neck dissection in primary head and neck cancer radio(chemo)therapy Nevens, D.
 2016
 119 S1 p. S244-S245
2 p.
 artikel
1847 PV-0039: Urinary incontinence rates in salvage high-dose-rate brachytherapy prostate cancer patients Wojcieszek, P.
 2016
 119 S1 p. S16-
1 p.
 artikel
1848 PV-0561: Validation of an optimised MC dose prediction for low energy X-rays intraoperative radiation therapy Ibáñez, P.
 2016
 119 S1 p. S269-S270
2 p.
 artikel
1849 PV-0278: Volume concepts in routine radiotherapy for localized Hodgkin lymphoma: results of a national survey Mazeron, R.
 2016
 119 S1 p. S129-S130
2 p.
 artikel
1850 Results of phase I trials combining PARP inhibition and radiotherapy in multiple sites Verheij, M.
 2016
 119 S1 p. S138-
1 p.
 artikel
1851 SP-0407: Abdominal-pelvic targets Hoyer, M.
 2016
 119 S1 p. S190-
1 p.
 artikel
1852 SP-0202: Ablative treatment for renal cancer Baumert, H.
 2016
 119 S1 p. S92-
1 p.
 artikel
1853 SP-0523: ACROP: General procedures, SOPs and current status Belka, C.
 2016
 119 S1 p. S248-
1 p.
 artikel
1854 SP-0106: Active surveillance: challenges and perspectives. The clinician point of view Valdagni, R.
 2016
 119 S1 p. S49-
1 p.
 artikel
1855 SP-0398: Active surveillance for cardiovascular disease after Hodgkins lymphoma Daniels, L.
 2016
 119 S1 p. S186-
1 p.
 artikel
1856 SP-0486: Adaptive planning, dose delivery and verification with MRI based brachytherapy Kirisits, C.
 2016
 119 S1 p. S232-S233
2 p.
 artikel
1857 SP-0501: Adaptive practice and techniques in proton therapy of the lung Park, P.C.
 2016
 119 S1 p. S237-S238
2 p.
 artikel
1858 SP-0434: Adaptive radiation therapy by the example of head and neck cancer: is there any role for a RTT? Speleers, B.
 2016
 119 S1 p. S203-
1 p.
 artikel
1859 SP-0387: Advanced treatment strategies for head and neck cancer Budach, W.
 2016
 119 S1 p. S181-
1 p.
 artikel
1860 SP-0303: Against the motion Van Schil, P.
 2016
 119 S1 p. S140-S141
2 p.
 artikel
1861 SP-0625: Against the motion Kamphuis, M.
 2016
 119 S1 p. S296-
1 p.
 artikel
1862 SP-0336: Against the motion Sonke, J-J.
 2016
 119 S1 p. S155-
1 p.
 artikel
1863 SP-0623: Against the motion Knöös, T.
 2016
 119 S1 p. S296-
1 p.
 artikel
1864 SP-0495: Against the motion - against dinosaurs Bodis, S.
 2016
 119 S1 p. S235-
1 p.
 artikel
1865 SP-0629: Against the motion rebuttal Vogelius, I.R.
 2016
 119 S1 p. S297-
1 p.
 artikel
1866 SP-0338: Against the motion rebuttal Dekker, A.
 2016
 119 S1 p. S155-
1 p.
 artikel
1867 SP-0627: Against the motion: This house believes that standard fractionation will remain the standard-of-care for the majority of curative treatments by 2025 Overgaard, J.
 2016
 119 S1 p. S297-
1 p.
 artikel
1868 SP-0182: Anal cancer: current guidelines and remaining questions Sebag-Montefiore, D.
 2016
 119 S1 p. S86-
1 p.
 artikel
1869 SP-0508: An evaluation of GoldAnchor intraprostatic fiducial marker stability during radiotherapy Bodusz, D.
 2016
 119 S1 p. S240-
1 p.
 artikel
1870 SP-0101: A radiation systems biology view of radiation sensitivity of normal and tumour cells Unger, K.
 2016
 119 S1 p. S46-S47
2 p.
 artikel
1871 SP-0618: Are there early and late benefits of breast IMRT for improving dose distribution homogeneity? Pignol, J.P.
 2016
 119 S1 p. S294-
1 p.
 artikel
1872 SP-0597: Automated QA for radiotherapy treatment planning Petit, S.
 2016
 119 S1 p. S285-S286
2 p.
 artikel
1873 SP-0598: Automated QA using log files Hernandez, V.
 2016
 119 S1 p. S286-
1 p.
 artikel
1874 SP-0311: Automated treatment plan generation - the Zurich experience Krayenbuehl, J.
 2016
 119 S1 p. S144-S145
2 p.
 artikel
1875 SP-0599: Automation in patient specific QA using in vivo portal dosimetry Francois, P.
 2016
 119 S1 p. S286-S287
2 p.
 artikel
1876 SP-0008: Balancing toxicity and disease control in the evolution of radiotherapy technology O'Sullivan, B.
 2016
 119 S1 p. S3-S4
2 p.
 artikel
1877 SP-0103: Better systemic therapy Van Meerbeeck, J.
 2016
 119 S1 p. S47-S48
2 p.
 artikel
1878 SP-0192: Beyond accuracy: how can medical physics help improve treatment quality? Nyström, H.
 2016
 119 S1 p. S89-
1 p.
 artikel
1879 SP-0185: Big data in radiotherapy: technology, challenges and opportunities Dekker, A.
 2016
 119 S1 p. S87-
1 p.
 artikel
1880 SP-0569: Biology of high-energy proton and heavy ion particle therapy versus photon therapy: recent developments Pruschy, M.
 2016
 119 S1 p. S274-
1 p.
 artikel
1881 SP-0507: Bladder variability for pelvic radiotherapy: its approaches and impact Khoo, V.
 2016
 119 S1 p. S240-
1 p.
 artikel
1882 SP-0525: Brachytherapy and physics guidelines, update and introduction of recent guidelines Tanderup, K.
 2016
 119 S1 p. S248-S249
2 p.
 artikel
1883 SP-0301: Brachytherapy as a boost: the way to go? Hoskin, P.
 2016
 119 S1 p. S139-
1 p.
 artikel
1884 SP-0391: Brachytherapy for the pelvic region: status and perspective for the future - prostate Henry, A.
 2016
 119 S1 p. S183-
1 p.
 artikel
1885 SP-0390: Brachytherapy for the pelvic region: status and perspectives for the future - Gynaecology Mazeron, R.
 2016
 119 S1 p. S183-
1 p.
 artikel
1886 SP-0421: Brachytherapy pelvic and MRI-Linac combination Nomden, C.N.
 2016
 119 S1 p. S196-S197
2 p.
 artikel
1887 SP-0334: Cancer plans in Europe and radiotherapy needs assessment: can we dance a tango? Albreht, T.
 2016
 119 S1 p. S154-S155
2 p.
 artikel
1888 SP-0604: Challenges combining radiotherapy with immunotherapy Formenti, S.
 2016
 119 S1 p. S289-S290
2 p.
 artikel
1889 SP-0296: Challenges in combining radiation and chemo-radiation with PARP inhibitors Schellens, J.
 2016
 119 S1 p. S138-
1 p.
 artikel
1890 SP-0006: Challenges in MR guided radiotherapy Jonsson, J.
 2016
 119 S1 p. S2-S3
2 p.
 artikel
1891 SP-0401: Circulating tumour cells as biomarkers in lung radiotherapy Haslett, K.
 2016
 119 S1 p. S188-
1 p.
 artikel
1892 SP-0117: Clinical appplication of atlas-based autosegmentation for contouring of multiple treatment sites Ten Kley, M.
 2016
 119 S1 p. S53-
1 p.
 artikel
1893 SP-0114: Clinical evidence for in-room MRI guidance Keall, P.
 2016
 119 S1 p. S52-
1 p.
 artikel
1894 SP-0524: Clinical guidelines, update and introduction of recent clinical guidelines Niyazi, M.
 2016
 119 S1 p. S248-
1 p.
 artikel
1895 SP-0422: Clinical implementation of ART for cervix Seppenwoolde, Y.
 2016
 119 S1 p. S197-
1 p.
 artikel
1896 SP-0438: Clinical implications of secondary cancer risks in pediatric and adult patients Hodgson, D.
 2016
 119 S1 p. S204-
1 p.
 artikel
1897 SP-0592: Combining immunotherapy and anticancer agents: the right path to achieve cancer cure? Apetoh, L.
 2016
 119 S1 p. S284-
1 p.
 artikel
1898 SP-0405: Combining SBRT and immunotherapy: a promising approach? Herrera, F.
 2016
 119 S1 p. S189-S190
2 p.
 artikel
1899 SP-0030: Comparisons of treatment planning with photons and protons Enmark, M.
 2016
 119 S1 p. S12-
1 p.
 artikel
1900 SP-0500: Cone beam CT for adaptive proton therapy Both, S.
 2016
 119 S1 p. S237-
1 p.
 artikel
1901 SP-0197: Consequences of bowel cancer screening programmes Van Leerdam, M.
 2016
 119 S1 p. S91-
1 p.
 artikel
1902 SP-0216: Contouring of normal tissues in head and neck radiotherapy Hol, S.
 2016
 119 S1 p. S99-
1 p.
 artikel
1903 SP-0002: CRISPR/Cas9 technology: from cells to mice to stem cell therapy Te Riele, H.
 2016
 119 S1 p. S1-
1 p.
 artikel
1904 SP-0093: Did I do it right? What was the result? Process and outcomes in radiotherapy Barrett, A.
 2016
 119 S1 p. S44-
1 p.
 artikel
1905 SP-0181: DNA repair and response for beginners Borgmann, K.
 2016
 119 S1 p. S85-S86
2 p.
 artikel
1906 SP-0601: Does lean management improve patient safety culture? Simons, P.
 2016
 119 S1 p. S287-S288
2 p.
 artikel
1907 SP-0412: Does the prescription isodose matter? Guckenberger, M.
 2016
 119 S1 p. S191-S192
2 p.
 artikel
1908 SP-0104: Does (very) low risk prostate cancer really exist? Algaba, F.
 2016
 119 S1 p. S48-
1 p.
 artikel
1909 SP-0522: Dose prescription and treatment delivery at the voxel scale: a fantasy? Lee, J.
 2016
 119 S1 p. S247-S248
2 p.
 artikel
1910 SP-0388: Dose to water vs. dose to tissue in advanced treatment planning: myths, realities and concerns Reynaert, N.
 2016
 119 S1 p. S182-
1 p.
 artikel
1911 SP-0023: Dose verification Tanderup, K.
 2016
 119 S1 p. S9-
1 p.
 artikel
1912 SP-0411: Dosimetric aspects and robustness in treatment plan optimisation of small tumours Ahnesjö, A.
 2016
 119 S1 p. S191-
1 p.
 artikel
1913 SP-0435: Dosimetric impact of dose painting and replanning: ARTFORCE project Sonke, J.J.
 2016
 119 S1 p. S203-
1 p.
 artikel
1914 SP-0307: Dosimetric pros and cons of available PBI techniques Major, T.
 2016
 119 S1 p. S142-S143
2 p.
 artikel
1915 SP-0094: Do we need randomised clinical data to justify the use of SABR for primary and oligometastatic cancer? 2016
 119 S1 p. S44-
1 p.
 artikel
1916 SP-0189: e-Learning for Professionals in Radiation Oncology: What, Why and How? Berlanga Flores, A.
 2016
 119 S1 p. S88-
1 p.
 artikel
1917 SP-0503: European strategy Baumann, M.
 2016
 119 S1 p. S238-
1 p.
 artikel
1918 SP-0308: Evaluating the impact of clinical uncertainties on TCP/NTCP models in brachytherapy Nesvacil, N.
 2016
 119 S1 p. S143-
1 p.
 artikel
1919 SP-0333: Evaluation of radiotherapy utilisation in Belgium: patterns and possible causes of suboptimal use Van Eycken, E.
 2016
 119 S1 p. S154-
1 p.
 artikel
1920 SP-0177: Evidence-based education: Radiation Oncology's forgotten foundation? Turner, S.
 2016
 119 S1 p. S84-S85
2 p.
 artikel
1921 SP-0484: First two years clinical experience with low-field MR-IGRT-system practicality and future implications Michalski, J.M.
 2016
 119 S1 p. S231-S232
2 p.
 artikel
1922 SP-0588: Focal radiotherapy for multiple brain metastases Schiappacasse, L.
 2016
 119 S1 p. S282-
1 p.
 artikel
1923 SP-0300: Focal strategies: ready for prime time? Bossi, A.
 2016
 119 S1 p. S139-
1 p.
 artikel
1924 SP-0302: For the motion Franks, K.
 2016
 119 S1 p. S140-
1 p.
 artikel
1925 SP-0113: For the motion Lohr, F.
 2016
 119 S1 p. S52-
1 p.
 artikel
1926 SP-0335: For the motion Tree, A.
 2016
 119 S1 p. S155-
1 p.
 artikel
1927 SP-0622: For the motion Sterpin, E.
 2016
 119 S1 p. S296-
1 p.
 artikel
1928 SP-0624: For the motion Leech, M.
 2016
 119 S1 p. S296-
1 p.
 artikel
1929 SP-0337: For the motion rebuttal Wouters, B.
 2016
 119 S1 p. S155-
1 p.
 artikel
1930 SP-0628: For the motion (rebuttal):It is the small fraction sizes that need special pleading, not the large ones Nahum, A.
 2016
 119 S1 p. S297-
1 p.
 artikel
1931 SP-0494: For the motion - SIZE MATTERS Slotman, B.
 2016
 119 S1 p. S235-
1 p.
 artikel
1932 SP-0032: Fully automated treatment planning: benefits and potential pitfalls Damen, E.
 2016
 119 S1 p. S12-S13
2 p.
 artikel
1933 SP-0115: Functional and molecular imaging techniques and personalised radiotherapy Niyazi, M.
 2016
 119 S1 p. S52-
1 p.
 artikel
1934 SP-0433: Functional imaging for ART; biological bases and potential impact on clinical outcome Hoeben, B.
 2016
 119 S1 p. S202-S203
2 p.
 artikel
1935 SP-0011: Future selection practice for proton therapy: selection of patients based on treatment planning comparison and NTCP-modelling Langendijk, H.
 2016
 119 S1 p. S4-S5
2 p.
 artikel
1936 SP-0610: Gene expression alterations to carbon ion and X-irradiation Moreels, M.
 2016
 119 S1 p. S291-
1 p.
 artikel
1937 SP-0579: Gene expression profiles in tumours for PRO Alsner, J.
 2016
 119 S1 p. S277-S278
2 p.
 artikel
1938 SP-0188: General introduction to head and neck radiotherapy Gregoire, V.
 2016
 119 S1 p. S88-
1 p.
 artikel
1939 SP-0116: General recontouring with deformal registration Geets, X.
 2016
 119 S1 p. S52-S53
2 p.
 artikel
1940 SP-0403: Genomic breast cancer subtype classification for response prediction Somaiah, N.
 2016
 119 S1 p. S189-
1 p.
 artikel
1941 SP-0492: Genomics and imaging: a pas-de-deaux in response prediction Lyng, H.
 2016
 119 S1 p. S234-
1 p.
 artikel
1942 SP-0404: Genomic subtypes in prostate cancer and its influence in treatment response Bristow, R.
 2016
 119 S1 p. S189-
1 p.
 artikel
1943 SP-0314: Geriatric assessment is a requirement to effectively provide a quality radiotherapy service to the older person O'Donovan, A.
 2016
 119 S1 p. S146-
1 p.
 artikel
1944 SP-0219: Green Journal Overgaard, J.
 2016
 119 S1 p. S100-
1 p.
 artikel
1945 SP-0310: Growing importance of data-mining methods to select dosimetric/clinical variables in predictive models of toxicity Rancati, T.
 2016
 119 S1 p. S144-
1 p.
 artikel
1946 SP-0291: Guideline-based contouring and clinical audit systems Weltens, C.
 2016
 119 S1 p. S135-S136
2 p.
 artikel
1947 SP-0580: GWAS, SNPs and normal tissue toxicity for personalised radiation oncology West, C.
 2016
 119 S1 p. S278-
1 p.
 artikel
1948 SP-0190: Has higher accuracy in treatment delivery translated into noticeable improvements in clinical outcomes Burnet, N.
 2016
 119 S1 p. S88-
1 p.
 artikel
1949 SP-0488: Healthcare professional's perspective Sancho Pardo, G.
 2016
 119 S1 p. S233-
1 p.
 artikel
1950 SP-0232: How does QA impact on clinical outcomes? Weber, D.C.
 2016
 119 S1 p. S105-S106
2 p.
 artikel
1951 SP-0506: How do we select meaningful pre-clinical models for studies in radiation biology? De Ruysscher, D.
 2016
 119 S1 p. S239-S240
2 p.
 artikel
1952 SP-0231: How effective is current clinical trial QA? Miles, E.
 2016
 119 S1 p. S105-
1 p.
 artikel
1953 SP-0043: How strong is the current clinical evidence for protons and heavy ions ? Fossati, P.
 2016
 119 S1 p. S17-S18
2 p.
 artikel
1954 SP-0383: How to bring QUANTEC into the 21st century? Fiorino, C.
 2016
 119 S1 p. S179-S180
2 p.
 artikel
1955 SP-0199: How to delineate the CTV for rectal cancer? An international consensus Valentini, V.
 2016
 119 S1 p. S91-
1 p.
 artikel
1956 SP-0221: How to do a good manuscript review Muren, L.P.
 2016
 119 S1 p. S100-
1 p.
 artikel
1957 SP-0021: How to ensure the quality in brachytherapy treatment planning systems? Siebert, F.A.
 2016
 119 S1 p. S8-
1 p.
 artikel
1958 SP-0289: How to finish your residency / PhD project with a job offer as a physicist Verellen, D.
 2016
 119 S1 p. S135-
1 p.
 artikel
1959 SP-0287: How to finish your residency / PhD project with a job offer as a radiation oncologist Rivera, S.
 2016
 119 S1 p. S134-S135
2 p.
 artikel
1960 SP-0288: How to finish your residency / PhD project with a job offer as a radiobiologist Vozenin, M.C.
 2016
 119 S1 p. S135-
1 p.
 artikel
1961 SP-0290: How to finish your residency / PhD project with a job offer as a researcher Oelfke, U.
 2016
 119 S1 p. S135-
1 p.
 artikel
1962 SP-0615: How to optimise the potential of SBRT Ost, P.
 2016
 119 S1 p. S292-S293
2 p.
 artikel
1963 SP-0029: IAEA external audits for advanced radiotherapy - lessons learnt and their relevance for industrialised countries Izewska, J.
 2016
 119 S1 p. S11-S12
2 p.
 artikel
1964 SP-0207: Image-based radiobiological tumour control probability modelling Malinen, E.
 2016
 119 S1 p. S94-
1 p.
 artikel
1965 SP-0205: Image guided brachytherapy in vaginal cancer Fokdal, L.U.
 2016
 119 S1 p. S93-S94
2 p.
 artikel
1966 SP-0022: Imaging Hellebust, T.P.
 2016
 119 S1 p. S8-S9
2 p.
 artikel
1967 SP-0606: Imaging-genomics: identifying molecular phenotypes by integrating radiomics and genomics data 2016
 119 S1 p. S290-
1 p.
 artikel
1968 SP-0179: Imaging in lung cancer radiotherapy: beyond the "pictures" Bonomo, L.
 2016
 119 S1 p. S85-
1 p.
 artikel
1969 SP-0110: Imaging markers for response prediction: the clinical need Goh, V.
 2016
 119 S1 p. S50-S51
2 p.
 artikel
1970 SP-0409: Immunotherapy for HNSCC: an emerging paradigm? Guigay, J.
 2016
 119 S1 p. S190-S191
2 p.
 artikel
1971 SP-0423: Implementation of daily plan selection in rectum De Jong, R.
 2016
 119 S1 p. S197-S198
2 p.
 artikel
1972 SP-0026: Importance of b-value selection and geometrical accuracy in DW-MRI for radiotherapy Lambrecht, M.
 2016
 119 S1 p. S10-
1 p.
 artikel
1973 SP-0617: IMRT for lung cancer: current status and futuredevelopments Faivre-Finn, C.
 2016
 119 S1 p. S294-
1 p.
 artikel
1974 SP-0306: IMRT is the best for PBI Offersen, B.
 2016
 119 S1 p. S142-
1 p.
 artikel
1975 SP-0309: Incorporation of imaging-based features into predictive models of toxicity Brink, C.
 2016
 119 S1 p. S143-S144
2 p.
 artikel
1976 SP-0496: Indications to radiotherapy for lymphoma in 2016: what is standard of care and what remains controversial? Yahalom, J.
 2016
 119 S1 p. S236-
1 p.
 artikel
1977 SP-0594: Individualised image-guided adaptive therapy in Michigan: lessons learned from clinical trial implementation Balter, J.
 2016
 119 S1 p. S284-
1 p.
 artikel
1978 SP-0195: Inhibition of ATR kinase activity for the treatment of lung cancer Vendietti, F.
 2016
 119 S1 p. S90-
1 p.
 artikel
1979 SP-0620: In-room MR image-guided plan of the day Kashani, R.
 2016
 119 S1 p. S295-
1 p.
 artikel
1980 SP-0581: Integrative data analysis for PRO Gambacorta, M.A.
 2016
 119 S1 p. S278-
1 p.
 artikel
1981 SP-0490: Interaction between patients and professionals: a psychooncologist's view Van Hoof, E.
 2016
 119 S1 p. S234-
1 p.
 artikel
1982 SP-0603: Interaction of radiotherapy with molecular targeting agents Harari, P.
 2016
 119 S1 p. S289-
1 p.
 artikel
1983 SP-0330: Introduction: The HERO data on optimal versus actual utilisation of radiotherapy in Europe Crau, G.
 2016
 119 S1 p. S153-
1 p.
 artikel
1984 SP-0502: In-vivo range estimation and adaptive particle therapy Lomax, T.
 2016
 119 S1 p. S238-
1 p.
 artikel
1985 SP-0305: IORT is the best for PBI Orecchia, R.
 2016
 119 S1 p. S141-S142
2 p.
 artikel
1986 SP-0218: Late effects in patients treated for head and neck cancer Henneberg, K.
 2016
 119 S1 p. S100-
1 p.
 artikel
1987 SP-0019: Measuring anorectal toxicity and function Vordermark, D.
 2016
 119 S1 p. S8-
1 p.
 artikel
1988 SP-0437: Modelling of secondary cancer risks Schneider, U.
 2016
 119 S1 p. S203-S204
2 p.
 artikel
1989 SP-0498: Modern imaging and radiotherapy in lymphoma Mikhaeel, G.
 2016
 119 S1 p. S237-
1 p.
 artikel
1990 SP-0493: Molecular imaging for radiotherapy optimisation Jeraj, R.
 2016
 119 S1 p. S234-
1 p.
 artikel
1991 SP-0408: Molecular targeting with radiotherapy Harrington, K.
 2016
 119 S1 p. S190-
1 p.
 artikel
1992 SP-0112: MRI imaging of irradiated liver tissue for in vivo verification in particle therapy Richter, C.
 2016
 119 S1 p. S51-S52
2 p.
 artikel
1993 SP-0483: MRI Linac: physics perspective Raaymakers, B.
 2016
 119 S1 p. S231-
1 p.
 artikel
1994 SP-0485: MR-linac: Clinical introduction Schultz, C.
 2016
 119 S1 p. S232-
1 p.
 artikel
1995 SP-0126: MR-PET for radiation oncology: the imaging perspective Riklund, K.
 2016
 119 S1 p. S57-S58
2 p.
 artikel
1996 SP-0128: MR-PET for radiation oncology: the implementation issues Nyholm, T.
 2016
 119 S1 p. S58-
1 p.
 artikel
1997 SP-0127: MR-PET for radiation oncology: the sub-volume opportunities Thorwarth, D.
 2016
 119 S1 p. S58-
1 p.
 artikel
1998 SP-0304: Multicatheter brachytherapy is the best for APBI Strnad, V.
 2016
 119 S1 p. S141-
1 p.
 artikel
1999 SP-0389: Nanodosimetry: from radiation physics to radiation biology Rabus, H.
 2016
 119 S1 p. S182-S183
2 p.
 artikel
2000 SP-0024: Needs and technical requirements for functional MRI in radiotherapy Van der Heide, U.A.
 2016
 119 S1 p. S9-S10
2 p.
 artikel
                             2122 gevonden resultaten
 
<< vorige    volgende >>
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland